Page last updated: 2024-09-04

ivabradine and cardiovascular agents

ivabradine has been researched along with cardiovascular agents in 362 studies

Compound Research Comparison

Studies (ivabradine)	Trials (ivabradine)	Recent Studies (post-2010) (ivabradine)	Studies (cardiovascular agents)	Trials (cardiovascular agents)	Recent Studies (post-2010) (cardiovascular agents)
1,143	197	833	17,645	1,480	6,891

Research

Studies (362)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (0.55)	18.2507
2000's	19 (5.25)	29.6817
2010's	290 (80.11)	24.3611
2020's	51 (14.09)	2.80

Authors

Authors	Studies
Cambarrat, C; Peglion, JL; Prost, JF; Thollon, C; Vian, J; Vilaine, JP	1
Jeanniot, JP; Klippert, P; Lefèvre, C; Merdjan, H; Polvé, S	1
Baruscotti, M; Bucchi, A; Difrancesco, D	1
Bourassa, MG; Ford, I; Fox, K; Tardif, JC; Tendera, M	1
Compagnon, P; Iacob, M; Joannides, R; Lerebours, G; Menard, JF; Moore, N; Thuillez, C	1
Barsness, GW; Yang, EH	1
Büter, I; Gams, E; Hohlfeld, T; Schipke, JD; Schmitz-Spanke, S	1
Fox, K	1
Ferrari, R; Ford, I; Fox, K; Steg, PG; Tendera, M	2
Berdeaux, A; Bizé, A; Colin, P; Ghaleh, B; Lucats, L; Monnet, X	1
Filipova, S; López-Bescós, L; Martos, R	1
Brink, PR; Bucchi, A; Cohen, IS; Danilo, P; Plotnikov, AN; Robinson, RB; Rosen, MR; Shlapakova, I	1
Gres, P; Heusch, G; Schilawa, D; Schulz, R; Skyschally, A; van Caster, P	1
Kahan, T; Ponikowski, P; Tardif, JC	1
D'Orazio, N; Riccioni, G; Vitulano, N	1
Sajadieh, A	1
Riccioni, G	3
Agewall, S; Atar, D	1
Lévy, S; Macher, JP	1
Akdemir, R; Balci, M; Dogan, M; Kara, E; Murat, SN; Orcan, S	1
Rosano, GM; Vitale, C; Volterrani, M	1
Kolosova, MV; Komlev, AD; Kuzenkova, VE; Kuziaev, AI; Laskin, GM	1
Battler, A; Dvir, D	1
Akchurin, RS; Chernova, NA; Erastova, NV; Grishin, IR; Karpov, IuA; Latypov, RS; Lopukhova, VV; Mareev, IuV; Saidova, MA; Sapel'nikov, OV	1
Aydogdu, S; Canbay, A; Celebi, OO; Celebi, S; Diker, E	1
Böhm, M; Borer, JS; Dubost-Brama, A; Ford, I; Komajda, M; Lerebours, G; Swedberg, K; Tavazzi, L	2
Teerlink, JR	1
Hasenfuss, G	1
Carnes, CA; Lindsey, KJ; Ni, W; Phelps, MA; Riesen, SC; Schober, KE	1
Hong, N; Kang, SM; Oh, J; Won, H	1
Gupta, A; Sharma, YP	1
Bâldea, I; Leucuta, SE; Muntean, D; Neag, M; Popa, A; Vlase, L	1
Canet, E; Lerebours, G; Vilaine, JP	1
Glezer, MG; Saĭgitov, RT	1
Lopatin, IuM	1
Baczkó, I; Cerbai, E; Gy Papp, J; Jaeger, K; Koncz, I; Romanelli, MN; Szél, T; Varró, A	1
Carbajal, EV; Deedwania, PC	1
Kanorskiĭ, SG; Pokrovskiĭ, VM; Tregubov, VG	1
Bonadei, I; Bontempi, L; Curnis, A; D'Aloia, A; Dei Cas, L; Del Magro, F; Piovanelli, B; Vizzardi, E	1
Bonagura, JD; Li, X; Otoni, CC; Riesen, SC; Schober, KE; Smith, DN	1
Bonagura, JD; Cervenec, RM; Riesen, SC; Schober, KE	1
Jasińska-Stroschein, M; Orszulak-Michalak, D; Owczarek, J	1
Belmonte, C; González, O; Madrid, R; Orio, P; Parra, A; Viana, F	1
Alekseeva, IuM; Ardashev, AV; Fin'ko, VA; Potievskaia, VI; Sakovich, EA; Sitnikov, AV; Soiustova, EL	1
Cortez-Quiroga, G; Curotto-Grasiosi, J; Durán-Torralba, C; Fernández-Guerrero, M; Rus-Mansilla, C	1
Lim, WY; Woldman, S	1
Abrahamsson, P; Böhm, M; Borer, JS; Ford, I; Kober, L; Komajda, M; Lloyd, SM; Metra, M; Swedberg, K; Tavazzi, L	1
Gapon, LI; Kolesnikova, SN; Musikhina, NA; Petelina, TI; Utesheva, AB	1
Jacobshagen, C	1
Komajda, M	2
Deedwania, P	1
Böhm, M; Borer, JS; Ford, I; Komajda, M; Robertson, M; Swedberg, K; Tavazzi, L; van Veldhuisen, DJ; Voors, AA	1
De Santis, V; Frati, G; Greco, E; Tritapepe, L	1
Clark, AL; Cleland, JG; Parsons, S	1
Cavusoglu, Y; Mert, U; Morrad, B; Mutlu, F; Nadir, A; Ulus, T	1
Cacciani, F; Lux, RL; Zaniboni, M	1
Böhm, M; Borer, JS; Ford, I; Komajda, M; Manolis, AJ; Robertson, M; Swedberg, K; Tavazzi, L	1
Cowie, MR	1
Akyildiz, ZI; Ergene, O	1
Batatinha, JA; Belardinelli, L; Bonatti, R; Liu, G; Nearing, BD; Rajamani, S; Silva, AF; Verrier, RL; Zeng, D	2
Cocco, G; Jerie, P	1
Martinka, P; Stöckl, G; Zugck, C	1
Abdel-Barr, MG; Abdel-Salam, Z; Hussain, M; Nammas, W; Rayan, M; Saleh, A	1
Ebelt, H; Höpfner, F; Müller-Werdan, U; Nuding, S; Stöckl, G; Werdan, K	3
Chen, H; Hu, GX; Huang, CK; Lian, QQ; Shang-Guan, WN; Sun, W; Wang, Z; Wang, ZS; Zhang, XD; Zhu, GH	1
Böhm, M; Borer, JS; Deedwania, P; Kim, JB; Reil, JC	1
Bollmann, A; Hilbert, S; Hindricks, G; John, S; Kosiuk, J; Oebel, S	1
Garganeeva, AA; Shabanova, MV	1
Somlói, M; Toldy-Schedel, E; Tomcsányi, J	1
Beletsi, A; Branscombe, N; Karavidas, A; Kourlaba, G; Maniadakis, N; Milonas, C; Parissis, J	1
Bangalore, S; Messerli, FH; Schmieder, RE	1
Castriota, F; Cremonesi, A; De Luca, G; Fattori, R; Lupi, A; Marino, PN; Mirabella, F; Parisi, R; Rognoni, A; Secco, GG	1
Bongo, AS; Cavallino, C; Lupi, A; Rognoni, A; Rosso, R; Secco, GG	1
Dammann, P; Gent, S; Heusch, G; Kleinbongard, P; Neuhäuser, M	1
Baviera, EP; Di Franco, A; Lanza, GA; Mandalà, G; Marazia, S; Salerno, Y; Sarullo, FM; Sarullo, S; Vassallo, L; Vitale, G	1
Bett, GC; Kaplan, AD; Kim, JJ; Lin, B; London, B; Rasmusson, RL; Salama, G; Sun, B; Yang, L; Zhu, X	1
Boyalla, V; Clark, AL; Cleland, JG; Dicken, B; Dierckx, R; Parsons, S; Pellicori, P; Putzu, P	1
Bagriy, AE; Bagriy, EA; Malovichko, SI; Pricolota, AV; Pricolota, OA; Samoilova, OV; Schukina, EV	1
Caetano, J; Delgado Alves, J	1
Aksan, G; Demirelli, S; Gulel, O; Icli, A; Inci, S; Nar, G; Soylu, K; Yuksel, S	1
Alihanoglu, YI; Evrengul, H; Kaftan, HA; Ordu, S; Ozhan, H; Ozsoy, A; Tosun, M; Yildiz, BS	1
Böhm, M; Borer, JS; Camm, J; Ford, I; Komajda, M; Lainscak, M; Lloyd, SM; Reil, JC; Swedberg, K; Talajic, M; Tavazzi, L; Ukena, C	1
Sayer, GT; Tannenbaum, S	1
Charles, H; Cochrane, L; Elder, DH; Lang, CC; Mohan, M	1
Karchik'ian, PO; Saĭganov, SA	1
Bocchi, EA; Böhm, M; Borer, JS; Ford, I; Komajda, M; Swedberg, K; Tavazzi, L	1
Traynor, K	1
Dixit, D; Kimborowicz, K	1
Olshansky, B; Sullivan, RM	1
Glezer, MG	1
Bohm, M; Reil, JC	1
Astarita, C; Capuano, N; Cirillo, T; Coppola, A; Rigo, F; Romano, C; Tagliamonte, E	1
D'iakov, IN; Glezer, MG	1
Borer, JS; Ford, I; Kielhorn, A; Pocock, SJ; Rogers, JK	1
Böhm, M; Borer, JS; Ford, I; Francq, BG; Komajda, M; Swedberg, K; Tavazzi, L	1
Ferrari, R; Ford, I; Fox, K; Steg, PG; Tardif, JC; Tendera, M	1
Caminiti, G; Fossati, C; Rosano, G; Volterrani, M	1
Allée, G; Dillinger, JG; Henry, P; Levy, BI; Logeart, D; Maher, V; Manzo Silberman, S; Vitale, C	1
Agricola, E; Camici, PG; Maranta, F; Margonato, A; Rimoldi, O; Tondi, L	1
Annamaria, M; Calo, L; Cappato, R; De Ambroggi, G; de Ruvo, E; Foresti, S; Lupo, PP; Sciarra, L	1
Böhm, M; Borer, JS; Ford, I; Kindermann, I; Komajda, M; Lainscak, M; Maack, C; Robertson, M; Swedberg, K; Tavazzi, L	1
Pereira-Barretto, AC	2
Chmelarova, A; Fedacko, J; Jackova, L; Janicko, M; Jedlickova, L; Majernik, J; Merkovska, L; Novakova, B; Pella, D	1
Lopatin, YM	1
Nguyen, E; Weeda, ER; White, CM	1
Lüscher, TF	1
Chassany, O; Ferrari, R; Ford, I; Fox, K; Steg, PG; Tardif, JC; Tendera, M	1
Haddad, H; Yip, AM; Zhai, AB	1
Chaudhary, R; Freudenberger, R; Garg, J; Krishnamoorthy, P; Lanier, G; Martinez, MW; Shah, N	1
Brinkmann, J; Diedrich, A; Großhennig, A; Heusser, K; Jordan, J; Luft, FC; May, M; Mehling, H; Schroeder, C; Sweep, FC; Tank, J; Wenzel, D	1
Abbas, A; Muñoz, OC; Porres-Aguilar, M	1
Grammatikou, V; Kallistratos, M; Katsivas, A; Zarifis, J	2
Al-Kindi, SG; Oliveira, GH; Orasanu, G	1
Böhm, M; Borer, J; Ewen, S; Ford, I; Komajda, M; Mahfoud, F; Robertson, M; Swedberg, K; Tavazzi, L	1
Chan, PH; Huang, D; Lam, CC; Shea, PC; Siu, CW; Tse, HF; Yiu, KH	1
Al Kattani, N; Albuisson, E; Kimmoun, A; Levy, B; Louis, H; Wei, C	1
Cacciapuoti, F	1
Böhm, M; Borer, JS; Ewen, S; Ford, I; Komajda, M; Laufs, U; Lloyd, SM; Lopez-Sendon, J; Mahfoud, F; Ponikowski, P; Swedberg, K; Tavazzi, L	1
Enseleit, F; Flammer, AJ; Naegele, M; Ruschitzka, F	1
Korabathina, R; Wojnowich, K	1
Ayhan, S; Dönmez, İ; Erdem, A; Erdem, FH; Ozturk, S; Yazıcı, M	1
Berdeaux, A; Bizé, A; Ghaleh, B; Hittinger, L; Jozwiak, M; Melka, J; Rienzo, M; Sambin, L; Su, JB	1
Colombo, A; Fragasso, G; Fumero, A; Giannini, F; Godino, C; Maranta, F; Margonato, A; Oppizzi, M; Slavich, M	1
Chen, Q; Deng, W; Ke, D; Li, G; Wu, Z; Ye, L	1
Abed, HS; Fulcher, JR; Keech, AC; Kilborn, MJ	1
Aydınlar, A; Baran, İ; Çoşkun, H; Güllülü, S; Sağ, S	1
Ali, M; Arnold, N; Bowden, NP; Duckles, H; Evans, PC; Feng, S; Gijsen, FJ; Gsell, W; Halliday, I; Hose, R; Lawrie, A; Lungu, A; Luong, L; Mahmoud, M; Ridger, V; Schenkel, T; Spencer, T; Tremoleda, JL; van der Heiden, K; Villa-Uriol, MC; Wentzel, J; Wylezinska-Arridge, M; Xing, R	1
Cerny, D; Gloekler, S; Laurent, S; Messerli, FH; Rimoldi, SF; Seiler, C; Traupe, T	1
Anker, SD; Cowie, MR; Filippatos, GS; Komajda, M; Mengelle, B; Ponikowski, P; Tavazzi, L	1
Beyers, RJ; French, BA; Hossack, JA; Lin, D; O'Connor, DM; Piras, BA; Smith, RS	1
Al-Saadi, T; Al-Zakwani, I; Alshekaili, L; Sallam, M	1
Cowie, MR; Kansal, AR; Kielhorn, A; Krotneva, S; Tafazzoli, A; Yurgin, N; Zheng, Y	1
Bauersachs, J; Berliner, D; Böhm, M; Brehm, M; Haghikia, A; Hilfiker-Kleiner, D; König, T; Schäfer, A; Tongers, J	1
Davis, K; Dietrich, E	1
Patel, S; Veltri, K	1
Böhm, M; Borer, JS; Ford, I; Komajda, M; Moyne, A; Swedberg, K; Tavazzi, L	1
Psotka, MA; Teerlink, JR	1
Eren, M; Güvenç, RÇ; Güvenç, TS; Öz, D; Tanık, VO; Velibey, Y	1
Acconcia, MC; Barillà, F; Dominici, T; Gaudio, C; Mangieri, E; Martino, F; Pannarale, G; Pannitteri, G; Paravati, V; Tanzilli, G; Torromeo, C	1
Morales-Martínez de Tejada, Á	1
Díez-García, LF; Gálvez-Contreras, MC; Romero-León, JM	1
Bangalore, S; Messerli, FH; Rimoldi, SF	1
Bolorunduro, OB; Jha, SK; Oliphant, CS; Owens, RE	1
Agrawal, V; Kumar, N; Lohiya, B; Prajapati, R; Sihag, BK; Singh, TB; Subramanian, G	1
Kelm, M; Perings, S; Stöckl, G	1
Barge-Caballero, E; Crespo-Leiro, MG; Grille-Cancela, Z; Hermida-Prieto, M; Marrón-Liñares, GM; Marzoa-Rivas, R; Muñiz-García, J; Núñez, L; Paniagua-Martín, MJ; Suarez-Fuentetaja, N; Vazquez-Rodriguez, JM	1
Hein, L; Lother, A	1
Ayub-Ferreira, SM; Biselli, B; Bocchi, EA; Chizzola, P; Issa, VS; Lofrano-Alves, MS	1
Gong, TA; Hauptman, PJ; Vidic, A	1
de Silva, R; Giavarini, A	1
Bossi, E; Cinquetti, R; Marcozzi, C; Moriondo, A; Negrini, D; Reguzzoni, M; Solari, E	1
Bolduc, V; Des Rosiers, C; Lachance, D; Lauzier, B; Rivard, ME; Ruiz, M; Shi, Y; Tardif, JC; Thorin, E; Vaillant, F	1
Aksakal, E; Aksu, U; Gulcu, O; Kaymaz, C; Oduncu, V; Sevimli, S; Tanboğa, İH; Topçu, S; Ulusoy, FR	1
Balducci, F; Colaiori, I; Creta, A; Demartini, C; Di Sciascio, G; Mangiacapra, F; Minotti, G; Ricottini, E	1
Bertomeu-González, V; Bertomeu-Martínez, V; Bodí, V; Bosch, MJ; Chorro, FJ; Cordero, A; Fácila, L; Gallego, J; García-Blas, S; Llàcer, A; Llàcer, P; Mendizábal, A; Merlos, P; Miñana, G; Montagud, V; Morell, S; Núñez, J; Palau, P; Pedrosa, V; Sanchis, J; Santas, E	1
Başaran, Ö; Biteker, M; Doğan, V; Ergün, G	1
Li, G; Li, K; Liu, T; Liu, XS; Lu, Y; Zhang, N	1
D'Ettorre, E; De Benedittis, G; de Gregorio, C; Della Rosa, G; Distante, A; Piscitelli, P	1
Rosenberg, K	1
Fayssoil, A	1
Böhm, M; Borer, JS; Dorman, ED; Ford, I; Kansal, AR; Kielhorn, A; Komajda, M; Krotneva, S; Patel, HK; Tavazzi, L; Zheng, Y	1
Khachatryan, A; Sargsyan, T; Sisakian, H	1
Lopatin, YM; Vitale, C	1
Gunaparn, S; Phrommintikul, A; Ruttanaphol, A; Wongcharoen, W	1
Hancox, JC; Melgari, D; Ng, GA	1
Akl, Y; Baligh, E; ElGameel, U; Kandil, H; Kassem, HH; Mahmoud, K	1
Alshammari, TM	1
Adhyaru, B; Raj, L	1
Champion, S	1
Cook, JC; Patterson, JH; Rodgers, JE; Tran, RH	1
Böhm, M; Borer, JS; Deedwania, PC; Kim, JB	1
Allen, CJ; Guha, K; Hartley, A; Sharma, R	1
Balarini, MM; Balthazar, DS; Bouskela, E; Miranda, ML; Paes, LS; Santos, MS	1
Franz, M; Kretzschmar, D; Pistulli, R; Rohm, I; Schulze, PC; Stumpf, C; Yilmaz, A	1
Cao, X; Li, X; Sun, Z; Xia, H; Zhang, B	1
Fukumitsu, M; Inagaki, M; Kawada, T; Li, M; Sugimachi, M; Uemura, K; Zheng, C	1
Kallistratos, M; Katsivas, A; Zarifis, J	1
Knyazkova, II; Kuzminova, NV; Osovska, NY	1
Alfonso Manterola, F; Almenar Bonet, L; Ariza Solé, A; Arribas Ynsaurriaga, F; Bover Freire, R; Bueno, H; Coca Payeras, A; Díaz Molina, B; Evangelista Masip, A; Ferreira González, I; González Juanatey, JR; Jiménez Navarro, M; Lambert Rodríguez, JL; López de Sá, E; López Fernández, S; Manito Lorite, N; Marin Ortuño, F; Martín Asenjo, R; Mirabet Pérez, S; Pascual Figal, D; Pérez de Isla, L; Rodríguez Padial, L; Ruilope Urioste, LM; San Román Calvar, JA; Sánchez Fernández, PL; Segovia Cubero, J; Sionis Green, A; Sionis, A; Varela Román, A; Vázquez García, R; Zamorano Gómez, JL	1
Butler, J; Hamo, CE; Papadimitriou, L	2
Branscombe, N; Cowie, MR; Davies, A; Griffiths, A; Paracha, N; Sculpher, M	1
Borovac, JA; Camici, PG; Crea, F; Niccoli, G; Vetrugno, V	1
Bögeholz, N; Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Frommeyer, G; Kochhäuser, S; Pott, C; Sterneberg, M	1
Astashkin On Behalf Of The Linkor Study Investigators, EI; Glezer, MG	1
Odegova, AA; Tarlovskaya, EI	1
Kanorskiy, SG; Pokrovskiy, VM; Tregubov, VG	1
Borisenko, YV; Kanorsky, SG	1
Kiyakbaev, GK; Kobalava, ZD; Shavarov, AA	2
Poteshkina, NG; Troshina, AA	1
Sargento, L	1
Anguita, M; Hidalgo, FJ	1
Stöckl, G; Störk, S; Zugck, C	1
Bekele, T; Hailu, A; Mengesha, HG; Otieno, MG; Petrucka, P; Weldearegawi, B	1
Hayat, S; Li Kam Wa, ME; Lim, PB; Taraborrelli, P	1
Daniluk, J; Drop, B; Sawicka, KM; Szczyrek, M; Szpringer, M; Wawryniuk, A; Załuska, K; Załuska-Patel, K; Żółkowska, D; Łuszczki, JJ	1
Böhm, M; Cohen-Solal, A; Dominjon, F; Henon-Goburdhun, C; Isnard, R; Komajda, M; Metra, M; Pannaux, M; Pieske, B; Ponikowski, P; Voors, AA	1
Granzier, H; Slater, RE; Strom, JG	1
de Juan, J; Fontenla, A; Giacoman, S; López-Gil, M; Lozano, Á; Villagraz, L	1
Aydın, F; Bektur, S; Hüseyinoglu Aydın, A; Kıvrak, Y; Taşdelen, Y	1
Böhm, M; Borer, J; Cowie, M; Komajda, M; Lainscak, M; Nikolovska Vukadinović, A; Swedberg, K; Vukadinović, D	1
Butler, J; Papadimitriou, L	1
Bouvaist, H; Cosgrove, S; Ennezat, PV; Le Jemtel, TH; Marechaux, S; Vital Durand, D	1
Clem, JR; Heins, J	1
Chien, FJ; Eisen, HJ; Kim, DH	1
Dural, M; Iskenderov, K; Mert, GÖ; Mert, KU; Özen, A	1
Alhazmi, L; Ammari, Z; Dasa, O; Grubb, B; Karabin, B; Ruzieh, M; Sirianni, N	1
Berger, F; Bonnet, D; Daubeney, PEF; Jokinen, E; Kantor, PF	1
Dahlström, U; Das, D; Ezekowitz, JA; Fu, M; Howlett, J; Lund, LH; Savarese, G	1
Ebelt, H; Müller-Werdan, U; Nuding, S; Presek, P; Schröder, J; Werdan, K; Wienke, A	1
Dukkipati, SR; Koruth, JS; Lala, A; Pinney, S; Reddy, VY	1
Bemme, S; Gollisch, T; Weick, M	1
Kang, S; Li, CJ; Zhang, XM	1
Mathew, ST; Po, SS; Thadani, U	1
Böhm, M; Borer, JS; Ford, I; Komajda, M; Maack, C; Moyne, A; Swedberg, K; Tavazzi, L	1
Daubeney, PEF; Delle Donne, G; Prasad, SK; Rosés Noguer, F; Salukhe, T; Till, J	1
Bridgeman, MB; Dalal, KS	1
Kalra, PR; Kay, R; Rowell, N; Salek, MS; Sidorowicz, G; Spooner, C; Stevens, D; Taylor, J; Zachariah, D	1
Foley, PWX; Zivlas, C	1
Berdeaux, A; Bizé, A; Bouhemad, B; Ghaleh, B; Hittinger, L; Jozwiak, M; Melka, J; Rienzo, M; Sambin, L; Su, JB	1
Musiałek, P	1
Bocchi, EA; Guimarães, GV; Rassi, S	1
Brink, D	1
Brown, JN; Gee, ME; Watkins, AK; Young, EJA	1
Guang-Yi, C; Li-Sha, G; Yue-Chun, L	1
Anguita, M; Carrasco, F; Castillo, JC; Hidalgo, F	1
Adda, J; Akodad, M; Audurier, Y; Battistella, P; Belloc, C; Breuker, C; Castet-Nicolas, A; Chettouh, M; Cristol, JP; Curinier, C; Dupuy, AM; Fesler, P; Kalmanovich, E; Kuster, N; Lotierzo, M; Marques, S; Mercier, G; Roubille, C; Roubille, F; Solecki, K; Soltani, S; Verchere, A; Zerkowski, L	1
Chaanine, AH; Gladden, JD; Redfield, MM	1
Adena, MA; Hamann, G; Sindone, AP	1
Dvorianchikova, ZY; Gatsura, SV; Golosova, AN; Karamysheva, EI; Ulyanova, EA	1
Clements, JN; Meade, CM	1
Fukuda, K; Inagaki, M; Iwanaga, Y; Kakehi, K; Kawada, T; Miyamoto, T; Miyazaki, S; Shimizu, S; Sugimachi, M; Uemura, K; Yamamoto, H	1
Glezer, M; Karpov, Y; Vasyuk, Y	1
Banach, M; Bielecka-Dabrowa, A; Rysz, J; von Haehling, S	1
Brader, P; Kapl, M; Muster, V; Rainer, P; Reittner, P; Schmidt, A; Szolar, DH; Tillich, M; von Lewinski, D; von Lewinski, F; Wallner, M	1
Abdullaev, TA; Berkinbaev, SF; Chesnikova, AI; Cowie, MR; Dadashova, GM; Glezer, MG; Grebennikova, AA; Hayrapetyan, HG; Kipiani, ZV; Koziolova, NA; Kurlyanskaya, AK; Lopatin, YM; Pagava, ZM; Rakisheva, AG; Sisakian, HS; Tarlovskaya, EI; Tseluyko, VI; Voronkov, LG	1
Abbas, G; Hanif, M; Khan, MA; Majeed, A; Ranjha, NM	1
Aspromonte, N; Grande, D; Iacoviello, M	1
El-Gowilly, SM; El-Naggar, AE; Sharabi, FM	1
Abe, K; Arimura, T; Kamada, K; Kishi, T; Mannoji, H; Nishikawa, T; Saku, K; Sunagawa, G; Sunagawa, K; Tsutsui, H	1
Fragasso, G; Gemma, M; Godino, C; Margonato, A; Montanaro, C; Pinto, G; Salerno, A; Slavich, M; Spoladore, R; Tondi, L	1
Glezer, M	1
Chobanyan-Jürgens, K; Duncker, D; Heusser, K; Jordan, J; Luft, FC; May, M; Mehling, H; Schröder, C; Tank, J; Veltmann, C	1
Chen, S; Hu, Z; Li, B; Wang, Z; Yu, Y	1
Cilsal, E; Ergul, Y; Guzeltas, A; Ozgur, S; Ozturk, E; Ozyurt, A	1
Wu, A	1
Balla, C; Ferrari, R; Pavasini, R	1
Chow, SL; Depre, C; Page, RL	1
Klug, D; Vaksmann, G	1
Ali, N; Cubbon, RM; Kearney, MT; Patel, PA; Pinder, S; Roy, A; Witte, KK	1
Amour, J; Apert-Verneuil, C; Bouabdallah, K; Carbognani, D; Cholley, B; Moyne, A; Nguyen, LS; Squara, P; Thierry, S	1
Alonso Salinas, GL; Castejón Navarro, B; Cuadrado Berrocal, I; Díez, J; Hernández Navarro, I; Largo Aramburu, C; Osorio Ruiz, Á; Pascual Izco, M; Ramírez-Carracedo, R; Sanmartín, M; Saura Redondo, M; Zamorano, JL; Zaragoza, C	1
Anguita, M; Castillo, JC; Hidalgo, F	1
Babayigit, E; Cavusoglu, Y; Mert, GÖ; Mert, KU	1
Evans, PC; Gaalen, KV; Gijsen, FJH; Meester, EJ; Moerman, AM; Ridwan, RY; Van der Heiden, K; van der Steen, AFW; Xing, R	1
Andrey, JL; Aranda, R; Egido, J; Gomez, F; Gomez, R; Guzman, M; Pedrosa, MJ; Romero, SP	1
Dodd, K; Lampert, BC	1
Chan, CS; Chang, SL; Chen, SA; Chen, YC; Chen, YJ; Kao, YH; Lin, YK	1
Bakkehaug, JP; How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L	1
Casas, G; Francisco-Pascual, J; García-Dorado, D; Moya-Mitjans, À; Rivas-Gándara, N	1
Borisenko, YV; Kanorskiy, SG	1
Chen, S; Wu, X; Wu, Z; Ye, F; You, W	1
Koenig, SN; Mohler, PJ	1
Huang, L; Lu, Z; Sun, H; Tan, S; Wang, W; Xiang, X; Zhou, Y	1
Newale, S; Sathyamurthy, I	1
Brugts, JJ; Brunner-La Rocca, HP; Hoes, AW; Linssen, GC; Rademaker, PC; Schaafsma, HJ; Smeele, FJ; van de Kamp, HJ; van Drimmelen, AA; Westendorp, PH	1
Ghadimi, N; Hosseinifard, H; Kaveh, S; Lijassi, A; Mehr, AZ; Shabaninejad, H	1
Böhm, M; Custodis, F; Fries, P; Hohneck, AL; Laufs, U; Schirmer, SH; Schneider, G; Ströder, J; Wagenpfeil, S	1
Adorisio, R; Amodeo, A; Baban, A; Bertini, E; Calvieri, C; Cantarutti, N; Catteruccia, M; D'Amico, A; Drago, F; Filippelli, S; Perri, G	1
Agewall, S; Atar, D; Hall, TS; Marciniak, TA; Serebruany, VL	1
Akiyama, T; Iwanaga, Y; Kakehi, K; Miyazaki, S; Shimizu, S; Sonobe, T; Watanabe, H; Yamamoto, H	1
Asselbergs, FW; Bots, SH; Day, D; den Ruijter, HM; Eikendal, ALM; Groepenhoff, F; Miller, VM; Regitz-Zagrosek, V; Rochon, PA; Tannenbaum, C	1
Hegedusova, N; Mravec, B; Ondicova, K; Tibensky, M	1
Arboscello, E; Balbi, M; Bighin, C; Brunelli, C; Ghigliotti, G; Gualandi, F; Murialdo, R; Sarocchi, M; Sicbaldi, V; Spallarossa, P	1
Brofferio, A; Lin, F; Malaza, G; Pacak, K	1
Liu, CL; Xue, EZ; Zhang, MH	1
Cheema, K; Cheema, MA; Ullah, W; Zain, MA	1
Hu, XR; Jin, ZP; Liu, JY; Tang, FY; Zhou, XB; Zhu, JR	1
Bocchi, EA; Salemi, VMC	1
Kallistratos, MS; Katsi, V; Makris, T; Manolis, AJ; Skalis, G; Tousoulis, D; Tsioufis, K	1
Fujimoto, M; Higuchi, H; Honda-Wakasugi, Y; Kawai, H; Maeda, S; Miyake, S; Miyawaki, T; Nagatsuka, H	1
Ebner, J; Haechl, N; Hilber, K; Koenig, X; Todt, H	1
Chen, L; Hua, T; Yang, M; Yang, Z; Zou, Y	1
Miao, W; Pei, H; Su, GH; Wang, W; Xie, WZ; Zhao, D; Zhao, Z	1
Balaji, S; Krishna, MR; Kumar, RK; Kunde, MF	1
Amurthur, B; Anand, IS; Ardell, JL; DiCarlo, LA; Gregory, DD; KenKnight, BH; Libbus, I; Mittal, S; Monteiro, R; Premchand, RK; Sharma, K	1
Bobadilla, G; Bravo, C; Duarte, M; Guardamagna, C; Muñoz, P; Rossel, V; Verdugo, F	1
Ali, M; Banavalikar, B; Ghadei, M; Kottayan, A; Padmanabhan, D; Shenthar, J; Singha, SI; Valappil, SP	1
Baka, T; Simko, F	1
Ako, J; Hagiwara, N; Inomata, T; Ito, H; Kawasaki, Y; Kihara, Y; Momomura, SI; Saito, Y; Sakata, Y; Shimokawa, H; Tanaka, T; Tsutsui, H; Yamamoto, K; Yamashina, A; Yano, M	1
Chen, S; Meng, Z; Peng, J; Sun, K; Wang, J; Wang, Q; Zhou, S; Zhou, Y	1
Mar, PL; Raj, SR	1
Atar, D; Marciniak, TA; Serebruany, V	1
Blatchford, J; Deltour, N; Jacquot, E; Malouvier, A; Rivero-Ferrer, E; Salem, L	1
Chen, T; Fang, X; Huang, J; Xu, X; Zhao, Q; Zheng, J; Zhu, H	1
Jorsal, A; McMurray, JJV; Nielsen, JC; Nielsen, RR; Pryds, K; Sommer, A; Wiggers, H	1
Bernier, V; Bohm, M; Borer, JS; Bouabdallaoui, N; Ford, I; Komajda, M; O'Meara, E; Swedberg, K; Tardif, JC; Tavazzi, L	1
Bonadei, I; Carubelli, V; Dallapellegrina, L; Sciatti, E; Vizzardi, E	1
Cygankiewicz, I; Kaczmarek, K; Klingenheben, T; Poddebska, I; Ptaszyński, P; Urbanek, I; Wranicz, JK	1
Arias, MÁ; Arribas, F; Fontenla, A; Gómez de la Cámara, A; López-Gil, M; Matía-Francés, R; Mejía-Martínez, E; Miracle-Blanco, Á; Montilla, I; Pastor-Fuentes, A; Rey-Blas, JR; Salgado-Aranda, R; Tamargo-Menéndez, J; Toquero-Ramos, J	1
Bosco-Lévy, P; Droz-Perroteau, C; Favary, C; Jové, J; Lassalle, R; Moore, N	1
Joshi, S; Kumar, G; Kumar, V; Ramamurthy, R; Sharma, V; Tiwari, N	1
Ajufo, E; Das, SR; Fonarow, GC; Navar, AM; Pandey, A; Sumarsono, A; Vaduganathan, M	1
Adnot, S; Bedet, A; Derumeaux, G; Marcos, E; Mekontso Dessap, A; Ternacle, J; Voiriot, G	1
AlDhahri, F; Kharal, M; Mahmood, N; Rajendram, R	1
D'Orazio, N; Gammone, MA; Massari, F; Riccioni, G	1
Bollen Pinto, B; Chen, A; Dunaiceva, J; Elia, N; Rudiger, A; Walder, B	1
Broe, M; Damkier, P; Ennis, ZN; Hallas, J; Hansen, MR; Hróbjartsson, A; Olesen, M; Pareek, M; Paulsen, NH; Pottegård, A; Videbæk, L	1
Bigelow, R; Cole, RT; DeVore, AD; Fonarow, GC; Ginwalla, M; Heitner, JF; Hernandez, AF; Lala, A; Lanfear, DD; Mentz, RJ; Old, W; Patel, CB; Piña, IL; Salacata, AS; Tasissa, G	1
DiDomenico, RJ; Griffin, T; Hellenbart, EL	1
Aziz, Z; Beaser, AD; Kohli, U; Nayak, HM	1
Alvarez, JC; de la Grandamison, GL; Knapp-Gisclon, A; Mayer-Duverneuil, C; Rambaud, C; Zerah, M	1
Dalla Vecchia, LA; De Maria, B; Perego, F	1
Allalou, A; Ameur, A; Brooke, HL; de Geus, E; den Hoed, M; Dethlefsen, O; Emmanouilidou, A; Höijer, I; Ingelsson, E; Jumaa, S; Klingström, T; Mazzaferro, E; Snieder, H; Vicenzi, S; von der Heyde, B	1
Beak, YS; Choi, SH; Jang, JH; Kim, DH; Ko, KY; Kwan, J; Kwon, SW; Lee, MJ; Park, JH; Park, SD; Shin, SH; Woo, SI; Yoon, GS	1
Gluud, C; Jakobsen, JC; Maagaard, M; Nielsen, EE; Ning, L; Sethi, NJ; Yang, SH	1
Benstoem, C; Brandenburg, V; Breuer, T; Heussen, N; Kalvelage, C; Marx, G; Stoppe, C	1
Chen, H; Guo, R; Liu, Q; Luo, X; Xu, Y; Yan, S; Zhang, W; Zhong, X	1
Bangalore, S; Chen, C; Godoy, LC; Kaur, G; Mehta, PK; Morrone, D; Sidhu, MS	1
Abbas, M; Farooq, F; Imran, N	1
Beck, E; Dathe, K; Hoeltzenbein, M; Lehmann, ML; Schaefer, C	1
Golshan, S; Hsu, JC; Lo, HC; Ormiston, CK; Taub, PR; Zadourian, A	1
Imamura, T; Narang, N	1
Gabrielsson, J; Jirstrand, M; Martel, E; Pairet, N; Scheuerer, S; Wallman, M	1
Mackiewicz, U; Mączewski, M; Marciszek, M; Oknińska, M; Paterek, A; Zambrowska, Z	1
Chen, R; Huang, C; Liu, N; Sun, W; Xu, RA	1
Chang, HY; Chen, CH; Lan, WR; Lee, YH; Liao, FC; Lin, SI; Liu, PY; Tsai, CT; Wu, YJ	1
Ellis, MJ; Flannery, D; Jeklin, AT; La Gerche, A; Macefield, VG; Naughton, MT; Nilsen, K; Sully, F	1
Abdelkader, NF; Ahmed, MAE; Elbadawy, NN; Saad, MA	1
Besser, S; Imamura, T; Kinugawa, K; Narang, N	1
Imamura, T; Kinugawa, K	1
Aimoto, M; Kawakami, S; Nagasawa, Y; Takahara, A	1
Imamura, T; Kinugawa, K; Onoda, H; Uchida, K	1
Calo', L; Cicogna, F; de Ruvo, E; Martino, A; Politano, A; Rebecchi, M; Sette, A; Sgueglia, M; Volterrani, M	1
Baopeng, T; Caizhen, Q; Huiyuan, H; Jingmin, Z; Junbo, G; Wenhui, D; Yamei, X; Yuhui, Z	1
Besser, S; Hori, M; Imamura, T; Kinugawa, K; Narang, N	1
Imamura, T; Izumida, T; Kinugawa, K	1
Karpov, Y; Nedoshivin, A; Petrova, PTS	1
Chen, W; Fang, LG; Guo, XX; Lai, JZ; Li, JY; Lin, X; Liu, YX; Qian, H; Wu, W; Yang, J; Zhu, YL; Zhu, YY	1
Cui, D; Li, J; Liu, G; Liu, K; Lou, D; Lu, S; Ma, S; Pang, X; Wang, J; Wang, X; Wu, S; Xie, X; Xue, L; Yang, Z; Ye, F; Yu, H; Zhang, Y; Zhong, M	1
Bocchi, EA; Lima, IGCV	1
Penslar, J; Udupa, S	1
Abdin, A; Batailler, C; Böhm, M; Borer, J; Ford, I; Komajda, M; Mahfoud, F; Slawik, J; Swedberg, K; Tavazzi, L	1
Joury, A	1
Bartelds, B; de Hoog, M; de Jonge, RC; In 't Veld, YL; Kammeraad, J; Koch, BCP; Sassen, SD; Sylva, M	1

Reviews

97 review(s) available for ivabradine and cardiovascular agents

Article	Year
Physiology and pharmacology of the cardiac pacemaker ("funny") current. Pharmacology & therapeutics, 2005, Volume: 107, Issue:1 Topics: Amino Acid Sequence; Animals; Benzazepines; Cardiovascular Agents; Clonidine; Cyclic Nucleotide-Gated Cation Channels; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; Ivabradine; Nerve Tissue Proteins; Potassium Channels; Pyrimidines; Sinoatrial Node; Structure-Activity Relationship	2005
Evolving treatment strategies for chronic refractory angina. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:3 Topics: Acetanilides; Angina Pectoris; Arginine; Benzazepines; Cardiovascular Agents; Chronic Disease; Combined Modality Therapy; Counterpulsation; Electric Stimulation Therapy; Humans; Ivabradine; Myocardial Revascularization; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Spinal Cord	2006
[Selective I(f) channel inhibition: an alternative for treating coronary artery disease?]. Herz, 2006, Volume: 31, Issue:1 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Clonidine; Coronary Artery Disease; Humans; Isoindoles; Ivabradine; Phthalimides; Practice Guidelines as Topic; Practice Patterns, Physicians'	2006
Ivabradine: beyond heart rate control. Advances in therapy, 2009, Volume: 26, Issue:1 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Heart Failure; Heart Rate; Heart Transplantation; Humans; Ivabradine; Nitrates; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left	2009
Focus on ivabradine: a new heart rate-controlling drug. Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:2 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Heart Rate; Humans; Ivabradine; Risk Factors; Vision Disorders	2009
Ivabradine: from molecular basis to clinical effectiveness. Advances in therapy, 2010, Volume: 27, Issue:3 Topics: Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Heart Rate; Humans; Ivabradine; Sinoatrial Node; Ventricular Remodeling	2010
Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction. Advances in therapy, 2010, Volume: 27, Issue:4 Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Randomized Controlled Trials as Topic	2010
Conventional and novel drug therapeutics to relief myocardial ischemia. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Cardiovascular System; Coronary Artery Disease; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Nicorandil; Nitrates; Piperazines; Ranolazine	2010
Ivabradine: recent and potential applications in clinical practice. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:3 Topics: Angina Pectoris; Animals; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Risk Factors; Ventricular Dysfunction, Left	2011
Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine. Annals of the New York Academy of Sciences, 2011, Volume: 1222 Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Heart Failure; Heart Rate; Humans; Ivabradine; Models, Biological; Risk Assessment; Therapies, Investigational	2011
[From results of BEAUTIFUL trial to results of SHIFT trial: BEAUTIFUL possibility to make a SHIFT in current guidelines]. Kardiologiia, 2011, Volume: 51, Issue:5 Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Disease Progression; Evidence-Based Medicine; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Practice Guidelines as Topic; Randomized Controlled Trials as Topic	2011
Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina. The American journal of medicine, 2011, Volume: 124, Issue:8 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Ivabradine; Myocardial Revascularization; Nitrates; Piperazines; Ranolazine; Treatment Outcome	2011
The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine. Minerva medica, 2011, Volume: 102, Issue:5 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Cyclic Nucleotide-Gated Cation Channels; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Prognosis; Sinoatrial Node	2011
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications. British journal of hospital medicine (London, England : 2005), 2013, Volume: 74, Issue:2 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Digoxin; Drug Combinations; Heart Failure; Heart Failure, Systolic; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists	2013
[Late sodium current and calcium overload--pathogenesis and adequate treatment]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:16 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Atrial Fibrillation; Benzazepines; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Electrocardiography; Endothelium, Vascular; Heart Failure, Diastolic; Humans; Hypercalcemia; Ivabradine; Myocardial Ischemia; Nitrates; Piperazines; Ranolazine; Sodium; Sodium Channels; Sodium-Calcium Exchanger	2013
[Management of heart failure: a challenge for healthcare systems]. Bulletin de l'Academie nationale de medecine, 2012, Volume: 196, Issue:6 Topics: Benzazepines; Cardiac Resynchronization Therapy; Cardiotonic Agents; Cardiovascular Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Digitalis Glycosides; Disease Management; Drug Therapy, Combination; Heart Failure; Humans; Ivabradine; Multicenter Studies as Topic; Stroke Volume; Vasodilator Agents	2012
Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure. Drugs, 2013, Volume: 73, Issue:14 Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Heart Failure; Heart Rate; Humans; Ivabradine	2013
Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. The American journal of medicine, 2015, Volume: 128, Issue:3 Topics: Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Heart Rate; Humans; Ivabradine; Rest; Risk Factors; Treatment Outcome	2015
Wilder's principle: pre-treatment value determines post-treatment response. European heart journal, 2015, Mar-01, Volume: 36, Issue:9 Topics: Antihypertensive Agents; Benzazepines; Blood Pressure; Cardiovascular Agents; Heart Rate; Humans; Hypertension; Ivabradine; Randomized Controlled Trials as Topic	2015
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. Cardiovascular & hematological agents in medicinal chemistry, 2015, Volume: 13, Issue:1 Topics: Angina, Stable; Animals; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Trimetazidine	2015
Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy. Cardiovascular & hematological agents in medicinal chemistry, 2015, Volume: 13, Issue:1 Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Coronary Vessels; Heart Rate; Humans; Ivabradine	2015
Heart rate and cardiovascular protection. European journal of internal medicine, 2015, Volume: 26, Issue:4 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atherosclerosis; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Heart Failure; Heart Rate; Humans; Hypertension; Ivabradine; Myocardial Ischemia; Risk Factors	2015
Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction. Current opinion in cardiology, 2015, Volume: 30, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Heart Failure; Humans; Ivabradine; Mineralocorticoid Receptor Antagonists; Phosphodiesterase 5 Inhibitors; Renin-Angiotensin System; Spironolactone; Stroke Volume; Water-Electrolyte Imbalance	2015
Pharmacologic management of chronic stable angina. JAAPA : official journal of the American Academy of Physician Assistants, 2015, Volume: 28, Issue:6 Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Ivabradine; Nicorandil; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Vasodilator Agents	2015
Conventional management of inappropriate sinus tachycardia. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2016, Volume: 46, Issue:1 Topics: Adrenergic beta-Antagonists; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Evidence-Based Medicine; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Tachycardia, Sinus; Treatment Outcome	2016
Treatment of inappropriate sinus tachycardia with ivabradine. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2016, Volume: 46, Issue:1 Topics: Benzazepines; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Evidence-Based Medicine; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Tachycardia, Sinus; Treatment Outcome	2016
Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure. Advances in therapy, 2015, Volume: 32, Issue:10 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Hemodynamics; Humans; Ivabradine; Stroke Volume; Ventricular Remodeling	2015
A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction. Journal of clinical pharmacology, 2016, Volume: 56, Issue:8 Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Chronic Disease; Clinical Trials as Topic; Drug Combinations; Heart Failure; Humans; Ivabradine; Neprilysin; Prospective Studies; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan	2016
Heart rate and heart failure. Current opinion in cardiology, 2016, Volume: 31, Issue:2 Topics: Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Heart Failure; Heart Rate; Humans; Ivabradine; Outcome Assessment, Health Care; Ventricular Dysfunction, Left	2016
Ivabradine: Heart Failure and Beyond. Journal of cardiovascular pharmacology and therapeutics, 2016, Volume: 21, Issue:4 Topics: Animals; Benzazepines; Cardiovascular Agents; Heart Conduction System; Heart Failure; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Quality of Life; Recovery of Function; Treatment Outcome; Ventricular Function	2016
Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure. Current cardiology reports, 2016, Volume: 18, Issue:2 Topics: Angina, Stable; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Heart Rate; Humans; Ivabradine; Risk Factors; Treatment Outcome	2016
Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016, Volume: 16, Issue:2 Topics: Benzazepines; Cardiovascular Agents; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Quality of Life; Treatment Outcome	2016
Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease. Therapeutic advances in cardiovascular disease, 2016, Volume: 10, Issue:2 Topics: Angina, Stable; Benzazepines; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Oxygen Consumption; Ranolazine	2016
Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments. Swiss medical weekly, 2016, Volume: 146 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Stroke Volume; Vasodilator Agents	2016
Heart Failure Update: Outpatient Management. FP essentials, 2016, Volume: 442 Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiac Resynchronization Therapy; Cardiotonic Agents; Cardiovascular Agents; Diet, Sodium-Restricted; Digoxin; Diuretics; Drug Combinations; Exercise Therapy; Fatty Acids, Omega-3; Female; Heart Failure; Heart Transplantation; Hospice Care; Humans; Ivabradine; Mineralocorticoid Receptor Antagonists; Tetrazoles; Valsartan; Vasodilator Agents	2016
Effectiveness of Ivabradine in Treating Stable Angina Pectoris. Medicine, 2016, Volume: 95, Issue:14 Topics: Angina, Stable; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Randomized Controlled Trials as Topic; Treatment Outcome	2016
Inappropriate sinus tachycardia: focus on ivabradine. Internal medicine journal, 2016, Volume: 46, Issue:8 Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiovascular Agents; Diagnosis, Differential; Disease Management; Electrocardiography, Ambulatory; Heart Rate; Humans; Ivabradine; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Tachycardia, Sinus; Treatment Outcome	2016
Ivabradine (Corlanor) for Heart Failure. American family physician, 2016, Apr-15, Volume: 93, Issue:8 Topics: Atrial Fibrillation; Benzazepines; Bradycardia; Cardiovascular Agents; Drug Costs; Heart Failure; Humans; Hypertension; Ivabradine; Treatment Outcome	2016
New Novel Treatment Approaches for Heart Failure With Reduced Ejection Fraction. Journal of pharmacy practice, 2017, Volume: 30, Issue:5 Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Ivabradine; Randomized Controlled Trials as Topic; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan	2017
Ivabradine: Role in the Chronic Heart Failure Armamentarium. Circulation, 2016, May-24, Volume: 133, Issue:21 Topics: Benzazepines; Cardiovascular Agents; Chronic Disease; Clinical Trials as Topic; Heart Failure; Hospitalization; Humans; Ivabradine	2016
Ivabradine: A Review of Labeled and Off-Label Uses. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016, Volume: 16, Issue:5 Topics: Adrenergic beta-Antagonists; Benzazepines; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Heart Rate; Humans; Ivabradine; Off-Label Use	2016
Pharmacology of heart failure: From basic science to novel therapies. Pharmacology & therapeutics, 2016, Volume: 166 Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Chronic Disease; Clinical Trials as Topic; Drug Combinations; Guanylate Cyclase; Heart Failure; Humans; Ivabradine; Mineralocorticoid Receptor Antagonists; Myosins; Neprilysin; Practice Guidelines as Topic; Renin-Angiotensin System; Tetrazoles; Valsartan	2016
The Role of Ivabradine in the Management of Angina Pectoris. Cardiovascular drugs and therapy, 2016, Volume: 30, Issue:4 Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Heart Rate; Humans; Ivabradine	2016
The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients. Clinical cardiology, 2016, Volume: 39, Issue:10 Topics: Aged; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Chi-Square Distribution; Coronary Disease; Female; Humans; Incidence; Ivabradine; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors	2016
Effect of ivabradine on central aortic blood pressure in patients with stable coronary artery disease: What do we know? International journal of cardiology, 2016, Dec-01, Volume: 224 Topics: Arterial Pressure; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine; Treatment Outcome	2016
Ivabradine: Do the Benefits Outweigh the Risks? Journal of cardiovascular pharmacology and therapeutics, 2017, Volume: 22, Issue:3 Topics: Angina Pectoris; Benzazepines; Bradycardia; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Patient Safety; Recovery of Function; Risk Assessment; Risk Factors; Treatment Outcome; Ventricular Function, Left	2017
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF). Postgraduate medical journal, 2016, Volume: 92, Issue:1094 Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents	2016
Comment on: Ivabradine: A Review of Labeled and Off-Label Uses. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016, Volume: 16, Issue:6 Topics: Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Drug Utilization; Humans; Ivabradine; Off-Label Use	2016
Ivabradine. Handbook of experimental pharmacology, 2017, Volume: 243 Topics: Benzazepines; Cardiovascular Agents; Comorbidity; Diabetes Mellitus; Heart Failure; Hemodynamics; Hospitalization; Humans; Hypotension; Ivabradine; Pulmonary Disease, Chronic Obstructive; Quality of Life; Renal Insufficiency; Treatment Outcome	2017
Evolving therapies for the management of chronic and acute decompensated heart failure. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2016, Nov-01, Volume: 73, Issue:21 Topics: Acute Disease; Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Chronic Disease; Clinical Trials as Topic; Disease Management; Drug Combinations; Ferric Compounds; Heart Failure; Humans; Ivabradine; Maltose; Tetrazoles; Valsartan	2016
Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease. The American journal of cardiology, 2016, Dec-15, Volume: 118, Issue:12 Topics: Benzazepines; Cardiovascular Agents; Chronic Disease; Coronary Artery Disease; Heart Failure, Systolic; Heart Rate; Hospitalization; Humans; Ivabradine; Mortality; Quality of Life; Treatment Outcome; Ventricular Function, Left	2016
Ivabradine: A Current Overview. Current clinical pharmacology, 2016, Volume: 11, Issue:4 Topics: Animals; Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Ventricular Dysfunction, Left	2016
Heart failure guidelines: What's new? Trends in cardiovascular medicine, 2017, Volume: 27, Issue:5 Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Benzazepines; Biphenyl Compounds; Cardiology; Cardiovascular Agents; Drug Combinations; Guideline Adherence; Heart Failure; Humans; Ivabradine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Tetrazoles; Treatment Outcome; Valsartan	2017
Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering. International journal of cardiology, 2017, Jun-01, Volume: 236 Topics: Acute Coronary Syndrome; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Heart Rate; Humans; Ivabradine; Treatment Outcome	2017
Heart Failure Guidelines on Pharmacotherapy. Handbook of experimental pharmacology, 2017, Volume: 243 Topics: Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Diuretics; Drug Combinations; Heart Failure; Humans; Hydralazine; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Nitrates; Practice Guidelines as Topic; Severity of Illness Index; Stroke Volume; Tetrazoles; Valsartan; Vasodilator Agents	2017
Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials. BMC cardiovascular disorders, 2017, 04-28, Volume: 17, Issue:1 Topics: Aged; Angina, Stable; Benzazepines; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Disease Progression; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome	2017
Heart rate and its reduction in chronic heart failure and beyond. European journal of heart failure, 2017, Volume: 19, Issue:10 Topics: Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Heart Rate; Humans; Ivabradine; Prognosis; Risk Factors	2017
"Fast Track" Development and Approval Process for Heart Failure Therapeutics. Clinical pharmacology and therapeutics, 2017, Volume: 102, Issue:2 Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Drug Approval; Drug Combinations; Drug Discovery; Heart Failure; Humans; Ivabradine; Tetrazoles; United States; United States Food and Drug Administration; Valsartan	2017
Limited role and benefit of ivabradine in the treatment of angina and heart failure with reduced ejection fraction. Acta cardiologica, 2017, Volume: 72, Issue:6 Topics: Angina Pectoris; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome	2017
Pharmacologic Management for Heart Failure and Emerging Therapies. Current cardiology reports, 2017, 08-24, Volume: 19, Issue:10 Topics: Aminobutyrates; Benzazepines; Benzhydryl Compounds; Biphenyl Compounds; Cardiovascular Agents; Drug Combinations; Glucosides; Heart Failure; Humans; Ivabradine; Neuregulin-1; Recombinant Proteins; Relaxin; Stroke Volume; Tetrazoles; Urea; Valsartan	2017
The Clinical Use of Ivabradine. Journal of the American College of Cardiology, 2017, Oct-03, Volume: 70, Issue:14 Topics: Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Cyclic Nucleotide-Gated Cation Channels; Heart Rate; Humans; Ivabradine	2017
Ivabradine has a neutral effect on mortality in randomized controlled trials. Medicine, 2017, Volume: 96, Issue:40 Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Cause of Death; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Rest; Risk Factors; Treatment Outcome	2017
Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies. Heart rhythm, 2018, Volume: 15, Issue:2 Topics: Benzazepines; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Prospective Studies; Tachycardia, Sinus; Treatment Outcome	2018
Heart failure treatment: Keeping up with best practices. The Journal of family practice, 2018, Volume: 67, Issue:1 Topics: Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Biphenyl Compounds; Cardiac Rehabilitation; Cardiac Resynchronization Therapy; Cardiovascular Agents; Defibrillators, Implantable; Diuretics; Drug Combinations; Echocardiography; Heart Failure; Heart-Assist Devices; Humans; Ivabradine; Obesity; Physician's Role; Physicians, Family; Sleep Apnea, Obstructive; Stroke Volume; Tetrazoles; Valsartan	2018
Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018, Volume: 18, Issue:3 Topics: Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Postural Orthostatic Tachycardia Syndrome; Prospective Studies; Retrospective Studies; Treatment Outcome	2018
Role of Heart Rate Reduction in the Management of Myocarditis. Current pharmaceutical design, 2018, Volume: 24, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; Carvedilol; Heart Rate; Humans; Inflammation; Ivabradine; Myocarditis	2018
Heart Failure with Preserved Ejection Fraction. Annual review of medicine, 2018, 01-29, Volume: 69 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Dyspnea; Exercise Tolerance; Heart Failure; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Incidence; Inflammation; Ivabradine; Mineralocorticoid Receptor Antagonists; Mortality; Nitrates; Phosphodiesterase 4 Inhibitors; Risk Factors; Stroke Volume	2018
Novel drugs for heart rate control in heart failure. Heart failure reviews, 2018, Volume: 23, Issue:4 Topics: Cardiovascular Agents; Heart Failure; Heart Rate; Heart Ventricles; Humans; Ivabradine; Stroke Volume	2018
The effects of heart rate control in chronic heart failure with reduced ejection fraction. Heart failure reviews, 2018, Volume: 23, Issue:4 Topics: Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Stroke Volume	2018
Heart Failure. Annals of internal medicine, 2018, 06-05, Volume: 168, Issue:11 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors	2018
Treatment of Angina: Where Are We? Cardiology, 2018, Volume: 140, Issue:1 Topics: Adrenergic beta-Antagonists; Angina, Stable; Calcium Channel Blockers; Cardiovascular Agents; Chest Pain; Humans; Ivabradine; Nicorandil; Patient Selection; Practice Guidelines as Topic; Ranolazine; Treatment Outcome; Trimetazidine	2018
Role of ivabradine and heart rate lowering in chronic heart failure: guideline update. Expert review of cardiovascular therapy, 2018, Volume: 16, Issue:7 Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Heart Failure, Systolic; Heart Rate; Hospitalization; Humans; Ivabradine; Treatment Outcome; Ventricular Dysfunction, Left	2018
Effects of Ivabradine on Hemodynamic and Functional Parameters in Left Ventricular Systolic Dysfunction: a Systematic Review and Meta-analysis. Journal of general internal medicine, 2018, Volume: 33, Issue:9 Topics: Blood Pressure; Cardiovascular Agents; Exercise Tolerance; Hemodynamics; Humans; Ivabradine; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left	2018
The Use and Indication of Ivabradine in Heart Failure. Heart failure clinics, 2018, Volume: 14, Issue:4 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine	2018
[Chronic Heart Failure With Preserved Ejection Fraction: Effective Treatment Possible?] Kardiologiia, 2018, Volume: 58, Issue:6 Topics: Adrenergic beta-Antagonists; Aged; Cardiovascular Agents; Chronic Disease; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Stroke Volume; Treatment Outcome; Ventricular Function, Left	2018
Ivabradine: Evidence and current role in cardiovascular diseases and other emerging indications. Indian heart journal, 2018, Volume: 70 Suppl 3 Topics: Cardiovascular Agents; Cardiovascular Diseases; Cause of Death; Global Health; Humans; Ivabradine; Survival Rate	2018
Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis. International journal of clinical pharmacy, 2019, Volume: 41, Issue:1 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Mitral Valve Stenosis; Randomized Controlled Trials as Topic; Treatment Outcome	2019
Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature. JACC. Heart failure, 2019, Volume: 7, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Heart Failure; Humans; Ivabradine; Male; Mineralocorticoid Receptor Antagonists; Mortality; Practice Guidelines as Topic; Research Design; Research Report; Sex Distribution; Sex Factors; Stroke Volume	2019
Ivabradine for treatment of heart failure. Expert opinion on drug safety, 2019, Volume: 18, Issue:5 Topics: Animals; Cardiovascular Agents; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Humans; Ivabradine; Practice Guidelines as Topic; Stroke Volume; Ventricular Function, Left	2019
Ivabradine and metoprolol in fixed dose combination: When, why and how to use it. Pharmacological research, 2019, Volume: 146 Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; Coronary Artery Disease; Drug Combinations; Heart Rate; Humans; Ivabradine; Metoprolol	2019
Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure. International heart journal, 2019, Jul-27, Volume: 60, Issue:4 Topics: Cardiovascular Agents; Exercise Tolerance; Heart Failure; Humans; Ivabradine; Stroke Volume; Ventricular Function, Left	2019
Pharmacology of Ivabradine and the Effect on Chronic Heart Failure. Current topics in medicinal chemistry, 2019, Volume: 19, Issue:21 Topics: Animals; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Ivabradine; Molecular Structure	2019
Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies. Annual review of medicine, 2020, 01-27, Volume: 71 Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Clonidine; Combined Modality Therapy; Female; Humans; Ivabradine; Male; Methyldopa; Postural Orthostatic Tachycardia Syndrome; Quality of Life; Risk Assessment; Severity of Illness Index; Survival Analysis; Treatment Outcome	2020
Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients? The American journal of medicine, 2020, Volume: 133, Issue:3 Topics: Cardiovascular Agents; Heart Failure; Humans; Ivabradine; Logistic Models; Randomized Controlled Trials as Topic	2020
Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials. Clinical therapeutics, 2019, Volume: 41, Issue:10 Topics: Angina Pectoris; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome	2019
The role of heart rate and ivabradine in acute heart failure. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2019, Oct-07, Volume: 89, Issue:3 Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiovascular Agents; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Myocardial Contraction; Patient Discharge; Prognosis; Tachycardia	2019
Beneficial effect of ivabradine against cardiovascular diseases. Frontiers in bioscience (Scholar edition), 2020, 03-01, Volume: 12, Issue:1 Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic	2020
Effect of ivabradine on major adverse cardiovascular events and mortality in critically ill patients: a systematic review and meta-analyses of randomised controlled trials with trial sequential analyses. British journal of anaesthesia, 2020, Volume: 124, Issue:6 Topics: Cardiovascular Agents; Critical Illness; Heart Diseases; Humans; Ivabradine; Treatment Outcome	2020
Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials. The American journal of medicine, 2020, Volume: 133, Issue:6 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Cause of Death; Drug Therapy, Combination; Heart Failure; Humans; Ivabradine; Mineralocorticoid Receptor Antagonists; Randomized Controlled Trials as Topic; Survival Rate	2020
Beyond Heart Failure and Ischemic Heart Disease: A Scoping Review of Novel Uses of Ivabradine in Adults. Pharmacotherapy, 2020, Volume: 40, Issue:6 Topics: Adult; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Sinoatrial Node	2020
Effects of adding ivabradine to usual care in patients with angina pectoris: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. Open heart, 2020, Volume: 7, Issue:2 Topics: Aged; Angina Pectoris; Cardiovascular Agents; Female; Humans; Ivabradine; Male; Middle Aged; Patient Safety; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome	2020
Ivabradine as adjuvant treatment for chronic heart failure. The Cochrane database of systematic reviews, 2020, 11-04, Volume: 11 Topics: Bias; Cardiovascular Agents; Cardiovascular Diseases; Chemotherapy, Adjuvant; Chronic Disease; Exercise Tolerance; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Stroke Volume	2020
Ivabradine in Cardiovascular Disease Management Revisited: a Review. Cardiovascular drugs and therapy, 2021, Volume: 35, Issue:5 Topics: Cardiovascular Agents; Cardiovascular Diseases; Humans; Ivabradine; Myocardial Ischemia; Prospective Studies; Randomized Controlled Trials as Topic; Stroke Volume; Tachycardia, Sinus	2021
Effect of ivabradine on cardiac arrhythmias: Antiarrhythmic or proarrhythmic? Heart rhythm, 2021, Volume: 18, Issue:7 Topics: Arrhythmias, Cardiac; Cardiovascular Agents; Heart Rate; Humans; Ivabradine	2021
Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction. The American journal of cardiology, 2021, 07-01, Volume: 150 Topics: Cardiovascular Agents; Digoxin; Heart Failure; Heart Rate; Humans; Ivabradine; Stroke Volume; Tachycardia	2021
Optimal Heart Rate Modulation Using Ivabradine. International heart journal, 2021, Jul-30, Volume: 62, Issue:4 Topics: Cardiac Output; Cardiovascular Agents; Echocardiography, Doppler; Heart Failure; Heart Rate; Humans; Ivabradine	2021
Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis. Advances in therapy, 2022, Volume: 39, Issue:9 Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Heart Rate; Humans; Ivabradine; Nitrates; Quality of Life; Treatment Outcome	2022

Trials

73 trial(s) available for ivabradine and cardiovascular agents

Article	Year
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. European heart journal, 2005, Volume: 26, Issue:23 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Exercise Tolerance; Female; Heart Conduction System; Humans; Ion Channels; Ivabradine; Male; Middle Aged	2005
Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise. British journal of clinical pharmacology, 2006, Volume: 61, Issue:2 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Benzazepines; Cardiovascular Agents; Cross-Over Studies; Depression, Chemical; Double-Blind Method; Epinephrine; Exercise; Heart Rate; Hemodynamics; Humans; Ivabradine; Male; Norepinephrine; Propranolol; Rest; Tilt-Table Test	2006
Long-term safety and efficacy of ivabradine in patients with chronic stable angina. Cardiology, 2007, Volume: 108, Issue:4 Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Female; Humans; Ivabradine; Male; Middle Aged; Treatment Outcome	2007
The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population. Cardiology, 2008, Volume: 110, Issue:4 Topics: Aged; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Ivabradine; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left	2008
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. European heart journal, 2009, Volume: 30, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Benzazepines; Blood Pressure; Cardiovascular Agents; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ion Channels; Ivabradine; Male; Middle Aged; Sinoatrial Node; Treatment Outcome; Young Adult	2009
Effect of ivabradine, a novel antianginal agent, on driving performance: A randomized, double-blind, placebo-controlled trial in healthy volunteers. Clinical drug investigation, 2009, Volume: 29, Issue:5 Topics: Adult; Automobile Driving; Benzazepines; Cardiovascular Agents; Computer Simulation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ivabradine; Male; Vision, Ocular; Young Adult	2009
Arrhythmic effects of ivabradine in patients with coronary artery disease. Clinical and investigative medicine. Medecine clinique et experimentale, 2009, Oct-01, Volume: 32, Issue:5 Topics: Adult; Aged; Arrhythmias, Cardiac; Benzazepines; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged	2009
[Effect of the I(f) channel blocker ivabradine on the parameters of external respiration function in patients with chronic obstructive pulmonary disease in its stable course period]. Terapevticheskii arkhiv, 2010, Volume: 82, Issue:3 Topics: Aged; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Electrocardiography; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Pulmonary Disease, Chronic Obstructive; Respiration; Respiratory Function Tests	2010
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet (London, England), 2010, Sep-11, Volume: 376, Issue:9744 Topics: Adult; Aged; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; Severity of Illness Index; Sinoatrial Node; Treatment Outcome	2010
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet (London, England), 2010, Sep-11, Volume: 376, Issue:9744 Topics: Adult; Aged; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Severity of Illness Index; Sinoatrial Node; Treatment Outcome	2010
[Antianginal efficacy and tolerability of ivabradine in the therapy of patients with stable angina: results of the CONTROL study]. Kardiologiia, 2010, Volume: 50, Issue:11 Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Depression, Chemical; Drug Monitoring; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Prognosis; Severity of Illness Index; Treatment Outcome	2010
[Alternative therapy with ivabradine in patients with functional class III chronic heart failure]. Kardiologiia, 2011, Volume: 51, Issue:8 Topics: Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Agents; Chronic Disease; Drug Monitoring; Drug Therapy, Combination; Echocardiography; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Hypertension; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Severity of Illness Index; Treatment Outcome	2011
Effects of treatment with ivabradine and atenolol on reproducibility of echocardiographic indices of left heart size and function in healthy cats. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 2012, Volume: 14, Issue:2 Topics: Animals; Atenolol; Atrial Function, Left; Benzazepines; Cardiovascular Agents; Cats; Double-Blind Method; Echocardiography; Female; Heart Atria; Heart Rate; Heart Ventricles; Ivabradine; Reproducibility of Results; Ventricular Function, Left	2012
Risk following hospitalization in stable chronic systolic heart failure. European journal of heart failure, 2013, Volume: 15, Issue:8 Topics: Aged; Aged, 80 and over; Benzazepines; Cardiovascular Agents; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Time Factors	2013
[Cerebral blood flow and endothelial functional activity in patients with coronary heart disease and arterial hypertension during therapy with ivabradine in combination with perindopril]. Terapevticheskii arkhiv, 2012, Volume: 84, Issue:12 Topics: Benzazepines; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Agents; Cerebrovascular Circulation; Coronary Disease; Drug Combinations; Electrocardiography; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Ivabradine; Male; Metoprolol; Middle Aged; Perindopril; Research Design; Treatment Outcome; Ultrasonography, Doppler	2012
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT. European journal of heart failure, 2014, Volume: 16, Issue:4 Topics: Adult; Aged; Benzazepines; Cardiovascular Agents; Creatinine; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Ivabradine; Kidney; Kidney Diseases; Male; Middle Aged	2014
Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure. Journal of cardiovascular medicine (Hagerstown, Md.), 2015, Volume: 16, Issue:9 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged	2015
Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT. European journal of heart failure, 2014, Volume: 16, Issue:7 Topics: Aged; Benzazepines; Blood Pressure; Cardiovascular Agents; Double-Blind Method; Female; Heart Failure, Systolic; Humans; Hypertension; Hypotension; Ivabradine; Male; Middle Aged; Prognosis; Systole; Treatment Outcome	2014
Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice. Advances in therapy, 2014, Volume: 31, Issue:9 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Quality of Life; Treatment Outcome	2014
I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life. Cardiology journal, 2015, Volume: 22, Issue:2 Topics: Adult; Aged; Benzazepines; Cardiomyopathy, Dilated; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Egypt; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Pilot Projects; Quality of Life; Stroke Volume; Surveys and Questionnaires; Time Factors; Treatment Outcome; Ventricular Function, Left	2015
Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study. Experimental gerontology, 2014, Volume: 59 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina, Stable; Benzazepines; Blood Pressure; Cardiovascular Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Nitrates; Psychometrics; Quality of Life; Retrospective Studies	2014
Ivabradine on aortic stiffness in patients with heart failure. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2015, Volume: 63, Issue:4 Topics: Aged; Aorta; Benzazepines; Cardiovascular Agents; Female; Follow-Up Studies; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Ultrasonography; Vascular Stiffness	2015
Effects of ivabradine therapy on heart failure biomarkers. Cardiology journal, 2015, Volume: 22, Issue:5 Topics: Aged; Benzazepines; Biomarkers; CA-125 Antigen; Cardiovascular Agents; Cystatin C; Down-Regulation; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Stroke Volume; Time Factors; Treatment Outcome; Turkey; Ventricular Function, Left	2015
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population. Cardiology, 2015, Volume: 131, Issue:4 Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Nebivolol; Propanolamines; Proportional Hazards Models; Treatment Outcome	2015
Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate. Advances in therapy, 2015, Volume: 32, Issue:8 Topics: Aged; Benzazepines; Bisoprolol; Blood Flow Velocity; Cardiovascular Agents; Coronary Artery Disease; Double-Blind Method; Drug Monitoring; Echocardiography, Doppler; Female; Fractional Flow Reserve, Myocardial; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Treatment Outcome	2015
Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients. Current medical research and opinion, 2015, Volume: 31, Issue:10 Topics: Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure, Systolic; Heart Rate; Hospitalization; Humans; Ivabradine; Numbers Needed To Treat; Proportional Hazards Models; Treatment Outcome	2015
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial. European journal of heart failure, 2015, Volume: 17, Issue:12 Topics: Benzazepines; Cardiovascular Agents; Diabetes Complications; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Prognosis	2015
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. European heart journal, 2015, Dec-07, Volume: 36, Issue:46 Topics: Aged; Atrial Fibrillation; Benzazepines; Bradycardia; Cardiovascular Agents; Coronary Artery Disease; Double-Blind Method; Female; Humans; Ivabradine; Male; Middle Aged; Risk Factors	2015
Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease. Hypertension (Dallas, Tex. : 1979), 2015, Volume: 66, Issue:6 Topics: Aged; Aorta; Benzazepines; Blood Pressure; Cardiovascular Agents; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Perfusion Imaging; Time Factors; Treatment Outcome	2015
Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia. Basic research in cardiology, 2015, Volume: 110, Issue:6 Topics: Aged; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Exercise; Hemodynamics; Humans; Ivabradine; Male; Middle Aged; Myocardial Stunning	2015
Ivabradine in Combination with Metoprolol Improves Symptoms and Quality of Life in Patients with Stable Angina Pectoris: A post hoc Analysis from the ADDITIONS Trial. Cardiology, 2016, Volume: 133, Issue:2 Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Angina, Stable; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Female; Germany; Heart Rate; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Nitrates; Prospective Studies; Quality of Life; Surveys and Questionnaires	2016
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial). The American journal of cardiology, 2015, Dec-15, Volume: 116, Issue:12 Topics: Aged; Benzazepines; Cardiovascular Agents; Comorbidity; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Female; Follow-Up Studies; Global Health; Heart Failure, Systolic; Heart Rate; Humans; Incidence; Ivabradine; Male; Middle Aged; Myocardial Infarction; Pulmonary Disease, Chronic Obstructive; Survival Rate; Treatment Outcome	2015
Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device. Advances in therapy, 2015, Volume: 32, Issue:10 Topics: Aged; Angina, Stable; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Endothelium, Vascular; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Ivabradine; Male; Middle Aged; Sinoatrial Node	2015
Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy. Circulation. Cardiovascular quality and outcomes, 2016, Volume: 9, Issue:1 Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Female; Humans; Ivabradine; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Visual Analog Scale	2016
Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping. Journal of the American Heart Association, 2016, Jan-13, Volume: 5, Issue:1 Topics: Adult; Autonomic Nervous System; Baroreflex; Benzazepines; Biological Clocks; Blood Pressure; Bradycardia; Cardiovascular Agents; Cross-Over Studies; Double-Blind Method; Electrocardiography; Germany; Healthy Volunteers; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Muscle Proteins; Muscle, Skeletal; Potassium Channels; Sinoatrial Node; Time Factors; Young Adult	2016
Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial. Journal of the American Heart Association, 2016, Feb-12, Volume: 5, Issue:2 Topics: Aged; Benzazepines; Blood Pressure; Cardiovascular Agents; Double-Blind Method; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Office Visits; Predictive Value of Tests; Risk Assessment; Risk Factors; Systole; Time Factors; Treatment Outcome	2016
Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:6 Topics: Aged; Benzazepines; Blood Pressure; Blood Pressure Determination; Cardiovascular Agents; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Linear Models; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Single-Blind Method; Stroke Volume; Treatment Outcome	2016
Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure. Current vascular pharmacology, 2016, Volume: 14, Issue:5 Topics: Adrenergic Antagonists; Aged; Benzazepines; Carbazoles; Cardiovascular Agents; Carvedilol; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Oman; Propanolamines; Prospective Studies; Quality of Life; Stroke Volume; Surveys and Questionnaires; Time Factors; Treatment Outcome; Ventricular Function, Left	2016
Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT. European journal of heart failure, 2016, Volume: 18, Issue:9 Topics: Aged; Benzazepines; Cardiovascular Agents; Disease Progression; Double-Blind Method; Female; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Patient Readmission; Treatment Outcome	2016
Ivabradine in Patients with ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: A Preliminary Randomized Prospective Study. Clinical drug investigation, 2016, Volume: 36, Issue:10 Topics: Acute Disease; Adult; Aged; Benzazepines; Cardiovascular Agents; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Risk Factors; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Ventricular Function, Left	2016
Metoprolol vs ivabradine in patients with mitral stenosis in sinus rhythm. International journal of cardiology, 2016, Oct-15, Volume: 221 Topics: Adolescent; Adult; Benzazepines; Cardiovascular Agents; Drug Monitoring; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Metoprolol; Mitral Valve Stenosis; Symptom Assessment; Treatment Outcome	2016
Control of sinus tachycardia as an additional therapy in patients with decompensated heart failure (CONSTATHE-DHF): A randomized, double-blind, placebo-controlled trial. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2016, Volume: 35, Issue:10 Topics: Benzazepines; Cardiovascular Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Tachycardia, Sinus; Time Factors; Treatment Outcome	2016
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study. Clinical research in cardiology : official journal of the German Cardiac Society, 2017, Volume: 106, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Benzazepines; Brachial Artery; Cardiovascular Agents; Coronary Artery Disease; Endothelium, Vascular; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Recovery of Function; Rome; Time Factors; Treatment Outcome; Vasodilation	2017
Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study. JACC. Heart failure, 2016, Volume: 4, Issue:11 Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; CA-125 Antigen; Cardiac Pacing, Artificial; Cardiovascular Agents; Cause of Death; Defibrillators, Implantable; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Monitoring, Physiologic; Mortality; Myocardial Revascularization; Natriuretic Peptide, Brain; Patient Care Planning; Patient Readmission; Peptide Fragments; Sodium Potassium Chloride Symporter Inhibitors; Spain; Treatment Outcome	2016
Metoprolol vs ivabradine in patients with mitral stenosis. International journal of cardiology, 2016, Nov-15, Volume: 223 Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Electrocardiography; Female; Follow-Up Studies; Humans; Ivabradine; Male; Metoprolol; Middle Aged; Mitral Valve Stenosis; Retrospective Studies; Treatment Outcome; Young Adult	2016
Effect of selective heart rate reduction through sinus node I Acta cardiologica, 2016, Volume: 71, Issue:3 Topics: Aged; Benzazepines; Cardiovascular Agents; Chronic Disease; Cyclic Nucleotide-Gated Cation Channels; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Pulse Wave Analysis; Severity of Illness Index; Sinoatrial Node; Treatment Outcome; Ventricular Dysfunction, Left	2016
Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation. International journal of cardiology, 2016, Dec-01, Volume: 224 Topics: Aged; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Double-Blind Method; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies	2016
The effect of ivabradine on functional capacity in patients with chronic obstructive pulmonary disease. Clinical medicine (London, England), 2016, Volume: 16, Issue:5 Topics: Aged; Benzazepines; Blood Pressure; Cardiovascular Agents; Exercise Test; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Walking	2016
Analyzing Health-Related Quality of Life Data to Estimate Parameters for Cost-Effectiveness Models: An Example Using Longitudinal EQ-5D Data from the SHIFT Randomized Controlled Trial. Advances in therapy, 2017, Volume: 34, Issue:3 Topics: Aged; Benzazepines; Cardiovascular Agents; Cost-Benefit Analysis; Female; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Models, Statistical; Quality of Life; Severity of Illness Index; Surveys and Questionnaires	2017
[Comparative Evaluation of -blockers and If-Channel Inhibitor in Patients With Chronic Heart Failure and Preserved Left Ventricular Ejection Fraction]. Kardiologiia, 2016, Volume: 56, Issue:2 Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Benzazepines; Bisoprolol; Cardiovascular Agents; Exercise Tolerance; Female; Heart Failure; Heart Ventricles; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Quality of Life; Stroke Volume; Ventricular Function, Left	2016
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial. European journal of heart failure, 2017, Volume: 19, Issue:11 Topics: Aged; Benzazepines; Cardiovascular Agents; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left	2017
Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure. Journal of the American College of Cardiology, 2017, Sep-05, Volume: 70, Issue:10 Topics: Adolescent; Benzazepines; Cardiomyopathy, Dilated; Cardiovascular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Infant; Ivabradine; Male; Quality of Life; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left	2017
Reducing Elevated Heart Rates in Patients with Multiple Organ Dysfunction Syndrome with The If (Funny Channel Current) Inhibitor Ivabradine. Shock (Augusta, Ga.), 2018, Volume: 49, Issue:4 Topics: Adrenergic beta-Antagonists; Aged; Cardiovascular Agents; Female; Heart Rate; Hemodynamics; Humans; Ivabradine; Middle Aged; Multiple Organ Failure	2018
Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT. European journal of heart failure, 2018, Volume: 20, Issue:2 Topics: Cardiovascular Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Heart Failure, Systolic; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left	2018
Quality of life improvement in older patients with heart failure initiated on ivabradine: Results from the UK multi-centre LIVE:LIFE prospective cohort study. International journal of cardiology, 2017, Dec-15, Volume: 249 Topics: Aged; Aged, 80 and over; Benzazepines; Cardiovascular Agents; Cohort Studies; Female; Follow-Up Studies; Heart Failure; Humans; Ivabradine; Male; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome; United Kingdom	2017
Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial. ESC heart failure, 2018, Volume: 5, Issue:3 Topics: Argentina; Brazil; Cardiovascular Agents; Chagas Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Stroke Volume; Survival Rate; Treatment Outcome; Ventricular Function, Left	2018
Evaluation of the sST2-guided optimization of medical treatments of patients admitted for heart failure, to prevent readmission: Study protocol for a randomized controlled trial. Contemporary clinical trials, 2018, Volume: 66 Topics: Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cardiovascular Agents; Drug Combinations; Female; Heart Failure; Humans; Interleukin-1 Receptor-Like 1 Protein; Ivabradine; Male; Mineralocorticoid Receptor Antagonists; Patient Care Planning; Patient Readmission; Sodium Potassium Chloride Symporter Inhibitors; Tetrazoles; Valsartan	2018
Cost-Effectiveness of Ivabradine in the Treatment of Chronic Heart Failure. Heart, lung & circulation, 2019, Volume: 28, Issue:3 Topics: Cardiovascular Agents; Cost-Benefit Analysis; Female; Health Care Costs; Heart Failure, Systolic; Humans; Ivabradine; Male; Quality of Life; Quality-Adjusted Life Years; Treatment Outcome	2019
Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study). Advances in therapy, 2018, Volume: 35, Issue:3 Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Canada; Cardiovascular Agents; Drug Monitoring; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Quality of Life; Treatment Outcome	2018
Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation. Scientific reports, 2018, 05-17, Volume: 8, Issue:1 Topics: Adolescent; Adult; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Cardiovascular Agents; Cross-Over Studies; Double-Blind Method; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Muscle Proteins; Pacemaker, Artificial; Potassium Channels; Prospective Studies; Young Adult	2018
Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial. Critical care (London, England), 2018, 08-17, Volume: 22, Issue:1 Topics: Administration, Intravenous; Aged; Cardiac Output, Low; Cardiotonic Agents; Cardiovascular Agents; Coronary Artery Bypass; Dobutamine; Elective Surgical Procedures; Female; Humans; Ivabradine; Male; Middle Aged; Placebos; Single-Blind Method	2018
Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease. Journal of hypertension, 2019, Volume: 37, Issue:5 Topics: Aged; Aorta; Arterial Pressure; Brachial Artery; Cardiovascular Agents; Chronic Disease; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Endothelium; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Pulse Wave Analysis; Vascular Stiffness; Vasodilation	2019
Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies. ESC heart failure, 2019, Volume: 6, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System; Biphenyl Compounds; Cardiovascular Agents; Drug Combinations; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Practice Guidelines as Topic; Quality of Life; Stroke Volume; Tetrazoles; Treatment Outcome; Vagus Nerve Stimulation; Valsartan; Ventricular Function, Left; Walk Test	2019
Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure　- J-SHIFT Study. Circulation journal : official journal of the Japanese Circulation Society, 2019, 09-25, Volume: 83, Issue:10 Topics: Aged; Cardiovascular Agents; Cause of Death; Chronic Disease; Disease Progression; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Japan; Male; Middle Aged; Patient Admission; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left	2019
Optimizing heart failure treatment following cardiac resynchronization therapy. Clinical research in cardiology : official journal of the German Cardiac Society, 2020, Volume: 109, Issue:5 Topics: Aged; Aged, 80 and over; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiac Resynchronization Therapy; Cardiovascular Agents; Drug Combinations; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan	2020
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m. ESC heart failure, 2019, Volume: 6, Issue:6 Topics: Aged; Cardiovascular Agents; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Stroke Volume	2019
Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project. Revista espanola de cardiologia (English ed.), 2020, Volume: 73, Issue:5 Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Agents; Digoxin; Equivalence Trials as Topic; Heart Rate; Humans; Ivabradine; Treatment Outcome	2020
PredischaRge initiation of Ivabradine in the ManagEment of Heart Failure: Results of the PRIME-HF Trial. American heart journal, 2020, Volume: 223 Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiovascular Agents; Chronic Disease; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Patient Discharge	2020
Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome. Journal of the American College of Cardiology, 2021, 02-23, Volume: 77, Issue:7 Topics: Adult; Cardiovascular Agents; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Ivabradine; Male; Norepinephrine; Postural Orthostatic Tachycardia Syndrome; Quality of Life	2021
Exercise oscillatory ventilation during autonomic blockade in young athletes and healthy controls. European journal of applied physiology, 2021, Volume: 121, Issue:9 Topics: Adult; Athletes; Breathing Exercises; Cardiovascular Agents; Case-Control Studies; Exercise; Exercise Test; Female; Heart Failure; Humans; Ivabradine; Male; Oxygen Consumption; Pulmonary Ventilation; Young Adult	2021
Implication of Ivabradine Therapy in Up-Titrating Beta-Blocker Dose in Patients with Systolic Dysfunction. International heart journal, 2021, Nov-30, Volume: 62, Issue:6 Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiovascular Agents; Echocardiography; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, Brain; Patient Readmission; Prospective Studies; Systole; Walk Test	2021
Ivabradine versus bisoprolol in the treatment of inappropriate sinus tachycardia: a long-term follow-up study. Journal of cardiovascular medicine (Hagerstown, Md.), 2021, Dec-01, Volume: 22, Issue:11 Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Bisoprolol; Cardiovascular Agents; Electrocardiography, Ambulatory; Exercise Test; Exercise Tolerance; Female; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tachycardia, Sinus; Treatment Outcome; Young Adult	2021
Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure. Journal of the American College of Cardiology, 2022, 08-09, Volume: 80, Issue:6 Topics: Benzazepines; Cardiovascular Agents; Delayed-Action Preparations; Double-Blind Method; Heart Failure; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left	2022

Other Studies

192 other study(ies) available for ivabradine and cardiovascular agents

Article	Year
Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. British journal of pharmacology, 1994, Volume: 112, Issue:1 Topics: Action Potentials; Animals; Benzazepines; Cardiac Pacing, Artificial; Cardiotonic Agents; Cardiovascular Agents; Electrophysiology; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Ivabradine; Male; Papillary Muscles; Purkinje Fibers; Rabbits; Sinoatrial Node	1994
Determination of ivabradine and its N-demethylated metabolite in human plasma and urine, and in rat and dog plasma by a validated high-performance liquid chromatographic method with fluorescence detection. Journal of chromatography. B, Biomedical sciences and applications, 1998, Nov-20, Volume: 719, Issue:1-2 Topics: Animals; Benzazepines; Calibration; Cardiovascular Agents; Chromatography, High Pressure Liquid; Dogs; Humans; Ivabradine; Rats; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence	1998
Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:9 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Nitrates; Randomized Controlled Trials as Topic; Sinoatrial Node	2006
Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in pa American heart journal, 2006, Volume: 152, Issue:5 Topics: Adult; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Double-Blind Method; Female; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Ventricular Dysfunction, Left	2006
Heart rate reduction by inhibition of If or by beta-blockade has different effects on postsystolic wall thickening. British journal of pharmacology, 2007, Volume: 150, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzazepines; Cardiovascular Agents; Dogs; Heart Rate; Heart Ventricles; Ivabradine; Myocardium; Physical Conditioning, Animal	2007
HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade. Heart rhythm, 2008, Volume: 5, Issue:2 Topics: Animals; Benzazepines; Calcium Channels; Cardiac Pacing, Artificial; Cardiovascular Agents; Catheter Ablation; Defibrillators, Implantable; Dogs; Electrophysiology; Ivabradine; Male; Muscle Cells; Rats; Risk Factors; Tachycardia, Ventricular	2008
Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. European heart journal, 2008, Volume: 29, Issue:18 Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Circulation; Drug Evaluation, Preclinical; Heart Rate; Ivabradine; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Swine; Swine, Miniature	2008
A new combination therapy in stable angina pectoris. European heart journal, 2009, Volume: 30, Issue:5 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Humans; Ivabradine; Treatment Outcome	2009
Interpreting clinical trials: the 'beautiful' case. Fundamental & clinical pharmacology, 2009, Volume: 23, Issue:2 Topics: Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Endpoint Determination; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left	2009
[Application of cardiac resynchronization therapy and ivabradine in a patient with chronic heart failure]. Kardiologiia, 2010, Volume: 50, Issue:7 Topics: Benzazepines; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiovascular Agents; Digoxin; Diuretics; Echocardiography; Electrocardiography; Furosemide; Heart Atria; Heart Failure; Heart Rate; Heart Ventricles; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Spironolactone; Treatment Outcome	2010
Inappropriate sinus tachycardia - successful treatment with ivabradine. Kardiologia polska, 2010, Volume: 68, Issue:8 Topics: Adolescent; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Female; Heart Rate; Humans; Ivabradine; Stroke Volume; Tachycardia, Sinus; Treatment Outcome	2010
Ivabradine in heart failure--no paradigm SHIFT…yet. Lancet (London, England), 2010, Sep-11, Volume: 376, Issue:9744 Topics: Aged; Benzazepines; Cardiovascular Agents; Female; Heart Failure, Systolic; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome	2010
Benefit of heart rate reduction in heart failure. Current heart failure reports, 2010, Volume: 7, Issue:4 Topics: Benzazepines; Cardiovascular Agents; Death, Sudden, Cardiac; Heart Failure; Heart Rate; Humans; Ivabradine; Life Expectancy; Randomized Controlled Trials as Topic	2010
[Patients with cardiovascular risk. SH/fT study: mortality rate reduced by a fourth]. MMW Fortschritte der Medizin, 2010, Oct-07, Volume: 152, Issue:40 Topics: Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Cyclic Nucleotide-Gated Cation Channels; Drug Therapy, Combination; Germany; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Multicenter Studies as Topic; Patient Admission; Survival Rate	2010
Pharmacokinetics of oral ivabradine in healthy cats. Journal of veterinary pharmacology and therapeutics, 2011, Volume: 34, Issue:5 Topics: Administration, Oral; Animals; Benzazepines; Cardiovascular Agents; Cat Diseases; Cats; Chromatography, Liquid; Female; Ivabradine; Reproducibility of Results; Tandem Mass Spectrometry	2011
Ivabradine and outcomes in chronic heart failure. Lancet (London, England), 2010, Dec-18, Volume: 376, Issue:9758 Topics: Benzazepines; Bundle-Branch Block; Cardiovascular Agents; Chronic Disease; Heart Failure; Heart Rate; Humans; Ivabradine; Patient Selection; Randomized Controlled Trials as Topic; Sinoatrial Node; Treatment Outcome	2010
Ivabradine and outcomes in chronic heart failure. Lancet (London, England), 2010, Dec-18, Volume: 376, Issue:9758 Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Heart Rate; Humans; Ivabradine; Mineralocorticoid Receptor Antagonists; Randomized Controlled Trials as Topic; Treatment Outcome	2010
Pharmacokinetic interaction between ivabradine and carbamazepine in healthy volunteers. Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:2 Topics: Adult; Anticonvulsants; Area Under Curve; Benzazepines; Biological Availability; Carbamazepine; Cardiovascular Agents; Drug Interactions; Half-Life; Heart Rate; Humans; Ivabradine; Male; Young Adult	2011
Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible therapeutical targets. Current medicinal chemistry, 2011, Volume: 18, Issue:24 Topics: Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Cyclic Nucleotide-Gated Cation Channels; Heart Diseases; Heart Rate; Humans; Ivabradine; Protein Isoforms; Sinoatrial Node	2011
Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy. American journal of veterinary research, 2012, Volume: 73, Issue:2 Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Benzazepines; Blood Pressure; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Cat Diseases; Cats; Dobutamine; Dose-Response Relationship, Drug; Heart Rate; Ivabradine; Propanolamines; Ventricular Function, Left	2012
Concomitant administration of different doses of simvastatin with ivabradine influence on PAI-1 and heart rate in normo- and hypercholesterolaemic rats. TheScientificWorldJournal, 2012, Volume: 2012 Topics: Acyl Coenzyme A; Animals; Benzazepines; Blood Pressure; Cardiovascular Agents; Cholesterol; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ivabradine; Lipids; Male; Models, Statistical; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; Risk Factors; Simvastatin	2012
Role of Ih in the firing pattern of mammalian cold thermoreceptor endings. Journal of neurophysiology, 2012, Volume: 108, Issue:11 Topics: Action Potentials; Animals; Benzazepines; Cardiovascular Agents; Cold Temperature; Cornea; Cyclic Nucleotide-Gated Cation Channels; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; Ivabradine; Mice; Models, Neurological; Nerve Endings; Optic Nerve; Potassium Channels; Pyrimidines; Thermoreceptors	2012
[The rare case of Bland-White-Garland syndrome in adult patient]. Kardiologiia, 2012, Volume: 52, Issue:11 Topics: Adult; Benzazepines; Cardiovascular Agents; Cardiovascular Surgical Procedures; Coronary Angiography; Coronary Vessel Anomalies; Coronary Vessels; Female; Heart Failure; Humans; Ivabradine; Metoprolol; Mitral Valve Insufficiency; Multidetector Computed Tomography; Prognosis; Pulmonary Artery; Syndrome; Treatment Outcome	2012
[Hemodynamic effect of ivabradine in three critical patients with severe aortic stenosis]. Medicina intensiva, 2014, Volume: 38, Issue:2 Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Benzazepines; Cardiovascular Agents; Female; Hemodynamics; Humans; Ivabradine	2014
SHIfT: Ivabradine's additional clinical benefits regardless of background beta-blocker dose. Cardiovascular journal of Africa, 2012, Volume: 23, Issue:6 Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiovascular Agents; Drug Administration Schedule; Drug Therapy, Combination; Heart Failure, Systolic; Heart Rate; Hospitalization; Humans; Ivabradine; Randomized Controlled Trials as Topic; Treatment Outcome	2012
Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome. Clinical research in cardiology : official journal of the German Cardiac Society, 2014, Volume: 103, Issue:10 Topics: Aged; Arrhythmias, Cardiac; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Sepsis; Treatment Outcome	2014
The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy. Clinical research in cardiology : official journal of the German Cardiac Society, 2014, Volume: 103, Issue:10 Topics: Adolescent; Benzazepines; Cardiomyopathy, Dilated; Cardiovascular Agents; Humans; Ivabradine; Male; Treatment Outcome; Ventricular Dysfunction, Left	2014
Beat-to-beat cycle length variability of spontaneously beating guinea pig sinoatrial cells: relative contributions of the membrane and calcium clocks. PloS one, 2014, Volume: 9, Issue:6 Topics: Acetylcholine; Action Potentials; Alkaloids; Animals; Benzazepines; Calcium; Cardiovascular Agents; Cholinergic Agonists; Guinea Pigs; Heart Rate; Ion Transport; Ivabradine; Male; Myocardial Contraction; Patch-Clamp Techniques; Periodicity; Primary Cell Culture; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sinoatrial Node; Sodium; Sodium-Calcium Exchanger	2014
Ivabradine and atrial fibrillation: what should we tell our patients? Heart (British Cardiac Society), 2014, Volume: 100, Issue:19 Topics: Angina Pectoris; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Medication Therapy Management; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment	2014
Frequency of angina and quality of life in outpatients with stable coronary artery disease in Turkey: insights from the PULSE study. Acta cardiologica, 2014, Volume: 69, Issue:3 Topics: Aged; Angina, Stable; Benzazepines; Cardiovascular Agents; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Nitroglycerin; Outcome Assessment, Health Care; Outpatients; Patient Acuity; Patient Preference; Prevalence; Quality of Life; Secondary Care Centers; Sex Factors; Tertiary Care Centers; Turkey	2014
If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation. Heart rhythm, 2014, Volume: 11, Issue:12 Topics: Analysis of Variance; Animals; Atrial Fibrillation; Atrioventricular Node; Benzazepines; Cardiac Catheterization; Cardiovascular Agents; Disease Models, Animal; Electrocardiography; Fluoroscopy; Guinea Pigs; Heart Conduction System; Heart Rate; Infusions, Intravenous; Ivabradine; Male; Pulse Therapy, Drug; Random Allocation; Reference Values; Sus scrofa; Swine; Ventricular Function, Left	2014
Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction. Cardiovascular toxicology, 2015, Volume: 15, Issue:1 Topics: Aged; Anti-Bacterial Agents; Azithromycin; Benzazepines; Cardiovascular Agents; Drug Interactions; Electrocardiography; Humans; Ivabradine; Male; Torsades de Pointes	2015
The effect of clopidogrel on pharmacokinetics of ivabradine and its metabolite in rats. Drug development and industrial pharmacy, 2015, Volume: 41, Issue:9 Topics: Animals; Area Under Curve; Benzazepines; Cardiovascular Agents; Chromatography, High Pressure Liquid; Clopidogrel; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Half-Life; Ivabradine; Male; Mass Spectrometry; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Ticlopidine	2015
Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation. Journal of cardiovascular electrophysiology, 2015, Volume: 26, Issue:3 Topics: Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Guinea Pigs; Heart Rate; Ivabradine; Male; Ranolazine; Swine	2015
Ivabradine for rate control in atrial fibrillation. International journal of cardiology, 2015, Jan-20, Volume: 179 Topics: Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Male; Middle Aged	2015
[Effect of optimal pulse slowing therapy on the course of recovery period in patients with ischemic heart disease after surgical myocardial revascularization]. Kardiologiia, 2014, Volume: 54, Issue:8 Topics: Benzazepines; Bisoprolol; Cardiovascular Agents; Comparative Effectiveness Research; Drug Monitoring; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Postoperative Complications; Tachycardia; Treatment Outcome	2014
Ivabradine and AV conduction. International journal of cardiology, 2015, Feb-15, Volume: 181 Topics: Atrial Flutter; Benzazepines; Bradycardia; Cardiovascular Agents; Catheter Ablation; Cyclic Nucleotide-Gated Cation Channels; Electrocardiography, Ambulatory; Humans; Ivabradine; Male; Middle Aged	2015
Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece. BMC health services research, 2014, Dec-11, Volume: 14 Topics: Benzazepines; Cardiovascular Agents; Chronic Disease; Cost-Benefit Analysis; Greece; Heart Failure; Humans; Ivabradine; Length of Stay; Markov Chains; Quality-Adjusted Life Years	2014
Heart rate reduction and longevity in mice. Basic research in cardiology, 2015, Volume: 110, Issue:2 Topics: Animals; Benzazepines; Cardiovascular Agents; Heart; Heart Rate; Ivabradine; Longevity; Male; Mice; Mice, Inbred C57BL; Myocardium	2015
Nemaline myopathy and heart failure: role of ivabradine; a case report. BMC cardiovascular disorders, 2015, Jan-19, Volume: 15 Topics: Adult; Benzazepines; Cardiovascular Agents; Echocardiography; Electrocardiography; Heart Failure; Humans; Ivabradine; Male; Myopathies, Nemaline; Treatment Outcome	2015
Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells. Journal of molecular and cellular cardiology, 2015, Volume: 81 Topics: Action Potentials; Aniline Compounds; Animals; Benzazepines; Caffeine; Calcium; Cardiovascular Agents; Cell Differentiation; Cell Line; Cellular Reprogramming; Connexin 43; Dependovirus; Genetic Vectors; Humans; Induced Pluripotent Stem Cells; Isoproterenol; Ivabradine; Microtubules; Myocytes, Cardiac; Patch-Clamp Techniques; Phenyl Ethers; Sarcoplasmic Reticulum; Sodium-Calcium Exchanger; Tetracaine; Transfection	2015
Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period. JACC. Heart failure, 2015, Volume: 3, Issue:3 Topics: Adrenergic beta-Antagonists; Aged; Appointments and Schedules; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Drug Prescriptions; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Outpatients; Retrospective Studies; Time Factors; Ventricular Function, Left	2015
Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention. Advances in therapy, 2015, Volume: 32, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Benzazepines; Canada; Cardiovascular Agents; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Nitrates; Percutaneous Coronary Intervention; Prospective Studies; Quality of Life	2015
Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study. Advances in therapy, 2015, Volume: 32, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Carbazoles; Cardiovascular Agents; Carvedilol; Drug Therapy, Combination; Exercise; Exercise Tolerance; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Propanolamines; Prospective Studies; Risk Factors; Ventricular Dysfunction, Left	2015
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy. European journal of heart failure, 2015, Volume: 17, Issue:5 Topics: Aged; Benzazepines; Cardiovascular Agents; Electrocardiography, Ambulatory; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies	2015
Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine. Cardiovascular therapeutics, 2015, Volume: 33, Issue:3 Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Bisoprolol; Cardiovascular Agents; Chronic Disease; Clinical Protocols; Drug Utilization; Female; Heart Failure; Hospitalization; Humans; Ivabradine; Male; Medication Therapy Management; Middle Aged; Retrospective Studies; United Kingdom	2015
[Correction of sinus rate by inhibitors of If-channels in patients with acute decompensated heart failure]. Kardiologiia, 2014, Volume: 54, Issue:11 Topics: Acute Disease; Aged; Benzazepines; Cardiovascular Agents; Dose-Response Relationship, Drug; Drug Monitoring; Echocardiography; Exercise Test; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Statistics as Topic; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left	2014
Ivabradine approved for stable chronic heart failure. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Jun-01, Volume: 72, Issue:11 Topics: Benzazepines; Cardiovascular Agents; Chronic Disease; Drug Approval; Heart Failure; Humans; Ivabradine; United States; United States Food and Drug Administration	2015
Ivabradine (Corlanor) for heart failure. The Medical letter on drugs and therapeutics, 2015, May-25, Volume: 57, Issue:1469 Topics: Adult; Benzazepines; Cardiovascular Agents; Drug Approval; Heart Failure; Humans; Ivabradine; United States; United States Food and Drug Administration	2015
[Effect of Treatment With Ivabradine on Quality of Life of Patients With Ischemic Heart Disease: Results of the LINCOR Program]. Kardiologiia, 2015, Volume: 55, Issue:2 Topics: Aged; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Female; Follow-Up Studies; Humans; Ivabradine; Male; Myocardial Ischemia; Program Evaluation; Quality of Life; Retrospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome	2015
Can ivabradine still be used in clinical practice after the 'SIGNIFY' trial? European heart journal, 2015, Jun-07, Volume: 36, Issue:22 Topics: Anti-Arrhythmia Agents; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Coronary Artery Disease; Humans; Ivabradine; Treatment Outcome	2015
[Clinical and Economic Efficacy of Ivabradine in Patients Suffered Myocardial Infarction]. Kardiologiia, 2015, Volume: 55, Issue:3 Topics: Benzazepines; Cardiovascular Agents; Cost-Benefit Analysis; Costs and Cost Analysis; Cyclic Nucleotide-Gated Cation Channels; Drug Costs; Humans; Ivabradine; Myocardial Infarction; Retrospective Studies	2015
Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance. International journal of cardiology, 2016, 01-01, Volume: 202 Topics: Aged; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male	2016
[Evaluation of the Antianginal Efficacy of Ivabradine In Patients With Ischemic Heart Disease Complicated by Heart Failure]. Kardiologiia, 2015, Volume: 55, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angina, Stable; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Female; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome	2015
Supraventricular and ventricular arrhythmias. European heart journal, 2015, Dec-07, Volume: 36, Issue:46 Topics: Anticoagulants; Arrhythmogenic Right Ventricular Dysplasia; Atrial Fibrillation; Benzazepines; Bradycardia; Cardiovascular Agents; Heart Diseases; Hemorrhage; Humans; Ivabradine; Point-of-Care Systems	2015
Ivabradine: more precautions to protect patients with coronary artery disease because of its cardiac harms. Prescrire international, 2015, Volume: 24, Issue:165 Topics: Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine	2015
Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study. Clinical cardiology, 2015, Volume: 38, Issue:12 Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Female; Greece; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Patient Compliance; Prospective Studies; Quality of Life; Treatment Outcome	2015
Ivabradine in Management of Heart Failure: a Critical Appraisal. Current heart failure reports, 2016, Volume: 13, Issue:1 Topics: Arrhythmias, Cardiac; Benzazepines; Cardiomyopathies; Cardiovascular Agents; Clinical Studies as Topic; Heart Failure; Heart Rate; Heart Transplantation; Humans; Ivabradine; Shock, Cardiogenic; Ultrasonography	2016
Ivabradine in Severe Aortic Stenosis with Poor Left Ventricular Ejection Fraction. The Journal of heart valve disease, 2015, Volume: 24, Issue:4 Topics: Aged, 80 and over; Aortic Valve Stenosis; Benzazepines; Cardiac Catheterization; Cardiovascular Agents; Electrocardiography; Heart Failure, Systolic; Heart Rate; Heart Valve Prosthesis Implantation; Humans; Ivabradine; Male; Recovery of Function; Severity of Illness Index; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left	2015
If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock. Shock (Augusta, Ga.), 2016, Volume: 46, Issue:3 Topics: Animals; Benzazepines; Cardiovascular Agents; Cecum; Echocardiography; Heart Rate; Hemodynamics; Interleukin-10; Interleukin-6; Ivabradine; Ligation; Male; Rats; Rats, Wistar; Shock, Septic; Tumor Necrosis Factor-alpha	2016
Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT. European journal of heart failure, 2016, Volume: 18, Issue:6 Topics: Aged; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Cause of Death; Double-Blind Method; Female; Heart Failure; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Medication Adherence; Middle Aged; Mortality; Placebos; Proportional Hazards Models; Randomized Controlled Trials as Topic	2016
Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization. Angiology, 2017, Volume: 68, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina, Stable; Cardiovascular Agents; Coronary Artery Disease; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Percutaneous Coronary Intervention; Quality of Life	2017
The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2016, Volume: 46, Issue:3 Topics: Benzazepines; Cardiovascular Agents; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left	2016
Improvement of left ventricular filling by ivabradine during chronic hypertension: involvement of contraction-relaxation coupling. Basic research in cardiology, 2016, Volume: 111, Issue:3 Topics: Animals; Benzazepines; Cardiovascular Agents; Disease Models, Animal; Female; Hemodynamics; Hypertension; Ivabradine; Swine; Ventricular Function, Left	2016
Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy. The American journal of cardiology, 2016, 05-15, Volume: 117, Issue:10 Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Echocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Ivabradine; Male; Myocardial Ischemia; Ranolazine; Retrospective Studies; Sodium Channel Blockers; Stroke Volume; Systole; Time Factors; Tomography, Emission-Computed, Single-Photon; Trimetazidine; Vasodilator Agents; Ventricular Function, Left	2016
Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine. Anatolian journal of cardiology, 2016, Volume: 16, Issue:3 Topics: Adult; Benzazepines; Cardiovascular Agents; Electrocardiography; Female; Humans; Ivabradine; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second; Prenatal Diagnosis; Tachycardia, Sinus	2016
Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteries. Thrombosis and haemostasis, 2016, 07-04, Volume: 116, Issue:1 Topics: Animals; Arteries; Arteritis; Benzazepines; Biomechanical Phenomena; Cardiovascular Agents; Endothelial Cells; Heart Rate; Human Umbilical Vein Endothelial Cells; Humans; Hypercholesterolemia; Ivabradine; Kruppel-Like Factor 4; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Stress, Mechanical; Vascular Cell Adhesion Molecule-1	2016
Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey. European journal of heart failure, 2016, Volume: 18, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Asia; Australia; Benzazepines; Canada; Cardiovascular Agents; Chronic Disease; Europe; Female; Guideline Adherence; Heart Failure; Humans; Ivabradine; Longitudinal Studies; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Practice Guidelines as Topic; Prospective Studies; Stroke Volume; Surveys and Questionnaires	2016
Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction. Journal of the American Heart Association, 2016, 04-22, Volume: 5, Issue:4 Topics: Animals; Benzazepines; Cardiovascular Agents; Disease Models, Animal; Echocardiography; Heart Rate; Heart Ventricles; Ivabradine; Magnetic Resonance Imaging, Cine; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Ventricular Function, Left; Ventricular Remodeling	2016
Cost-Effectiveness of Ivabradine for Heart Failure in the United States. Journal of the American Heart Association, 2016, 05-06, Volume: 5, Issue:5 Topics: Aged; Benzazepines; Cardiovascular Agents; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Markov Chains; Medicare Part C; Middle Aged; Proportional Hazards Models; Quality-Adjusted Life Years; United States	2016
Early ivabradine treatment in patients with acute peripartum cardiomyopathy: Subanalysis of the German PPCM registry. International journal of cardiology, 2016, Aug-01, Volume: 216 Topics: Benzazepines; Cardiomyopathy, Dilated; Cardiovascular Agents; Female; Germany; Humans; Ivabradine; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Registries; Stroke Volume; Treatment Outcome	2016
[Anti-angina fixed combination is available]. MMW Fortschritte der Medizin, 2016, Apr-28, Volume: 158, Issue:8 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Cardiovascular Agents; Combined Modality Therapy; Coronary Disease; Drug Combinations; Humans; Ivabradine; Metoprolol; Recurrence	2016
Could ivabradine challenge be helpful for the diagnosis of intermittent sinoatrial node dysfunction in suspected patients? Medical hypotheses, 2016, Volume: 92 Topics: Benzazepines; Cardiology; Cardiovascular Agents; Clinical Trials as Topic; Electrocardiography; Electrophysiology; Heart Rate; Humans; Ivabradine; Monitoring, Physiologic; Pacemaker, Artificial; Reproducibility of Results; Sick Sinus Syndrome; Sinoatrial Node; Syncope	2016
About Bradycardia and Secondary Heart Failure Induced by Ivabradine in a Patient With HIV. Revista espanola de cardiologia (English ed.), 2016, Volume: 69, Issue:8 Topics: Benzazepines; Bradycardia; Cardiovascular Agents; Heart Failure; Heart Rate; HIV; HIV Infections; Humans; Ivabradine	2016
About Bradycardia and Secondary Heart Failure Induced by Ivabradine in a Patient With HIV. Response. Revista espanola de cardiologia (English ed.), 2016, Volume: 69, Issue:8 Topics: Benzazepines; Bradycardia; Cardiovascular Agents; Heart Failure; Heart Rate; HIV; HIV Infections; Humans; Ivabradine	2016
[Increased physical capacity]. MMW Fortschritte der Medizin, 2016, May-12, Volume: 158, Issue:9 Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Combinations; Humans; Ivabradine; Metoprolol; Physical Fitness	2016
Ivabradine in Coronary Heart Disease-The Emperor Has No Clothes. The American journal of cardiology, 2017, 08-01, Volume: 120, Issue:3 Topics: Arterial Pressure; Cardiac Catheterization; Cardiovascular Agents; Coronary Artery Disease; Heart Rate; Humans; Ivabradine; Myocardium; Oxygen Consumption; Single-Blind Method; Stroke Volume; Treatment Outcome	2017
Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice. Advances in therapy, 2016, Volume: 33, Issue:9 Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Benzazepines; Cardiovascular Agents; Depression, Chemical; Drug Therapy, Combination; Female; Germany; Heart Rate; Humans; Ivabradine; Male; Medication Therapy Management; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome	2016
Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report. Cardiology journal, 2016, Volume: 23, Issue:5 Topics: Adult; Aged; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Female; Genotype; Heart Failure; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Middle Aged; Muscle Proteins; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Potassium Channels; RNA	2016
Variations on a Precision Medicine Theme: One Size Fits Some. Circulation. Heart failure, 2016, Volume: 9, Issue:8 Topics: Benzazepines; Cardiovascular Agents; Clinical Decision-Making; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; Humans; Ivabradine; Patient Selection; Precision Medicine; Prosthesis Design; Risk Factors; Treatment Outcome	2016
Hyperpolarization-activated cyclic nucleotide-gated channels in peripheral diaphragmatic lymphatics. American journal of physiology. Heart and circulatory physiology, 2016, 10-01, Volume: 311, Issue:4 Topics: Animals; Benzazepines; Cardiovascular Agents; Cesium; Chlorides; Diaphragm; Female; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Immunohistochemistry; Ivabradine; Lymphatic Vessels; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Potassium Channels; Pyrimidines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Vasoconstriction	2016
Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia. American journal of physiology. Heart and circulatory physiology, 2016, 10-01, Volume: 311, Issue:4 Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Benzazepines; Bradycardia; Cardiovascular Agents; Disease Models, Animal; Dyslipidemias; Echocardiography; Energy Metabolism; Female; Glucose; Glycolysis; Heart; Heart Rate; Hemodynamics; Ivabradine; Longitudinal Studies; Male; Metoprolol; Mice; Myocardium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stroke Volume; Telemetry; Transcriptome	2016
Ivabradine and atrial fibrillation: A double-edged sword. International journal of cardiology, 2016, Nov-15, Volume: 223 Topics: Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Humans; Ivabradine	2016
Effect of Ivabradine in dilated cardiomyopathy from Duchenne muscular dystrophy: A chance for slowing progression of heart failure? International journal of cardiology, 2016, 11-15, Volume: 223 Topics: Adult; Benzazepines; Cardiomyopathy, Dilated; Cardiovascular Agents; Disease Progression; Heart Failure; Humans; Ivabradine; Male; Muscular Dystrophy, Duchenne; Treatment Outcome	2016
New Recommendations for Heart Failure Treatment. The American journal of nursing, 2016, Volume: 116, Issue:9 Topics: Antihypertensive Agents; Benzazepines; Cardiovascular Agents; Heart Failure; Humans; Ivabradine; Practice Guidelines as Topic; Valsartan	2016
Which place for ivabradine in Duchenne muscular dystrophy with heart failure? International journal of cardiology, 2016, Nov-15, Volume: 223 Topics: Benzazepines; Blood Gas Analysis; Cardiovascular Agents; Electrocardiography; Heart Failure; Humans; Ivabradine; Male; Muscular Dystrophy, Duchenne	2016
Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States. Journal of managed care & specialty pharmacy, 2016, Volume: 22, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Budgets; Cardiovascular Agents; Drug Costs; Female; Heart Failure, Systolic; Humans; Insurance Claim Review; Insurance, Health; Ivabradine; Male; Medicare Part C; Middle Aged; Pharmacopoeias as Topic; Retrospective Studies; Standard of Care; United States; Young Adult	2016
Letter by Melgari et al Regarding Article, "Ivabradine: Role in the Chronic Heart Failure Armamentarium". Circulation, 2016, 09-27, Volume: 134, Issue:13 Topics: Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Heart Rate; Humans; Ivabradine; Treatment Outcome	2016
Ivabradine Attenuates the Microcirculatory Derangements Evoked by Experimental Sepsis. Anesthesiology, 2017, Volume: 126, Issue:1 Topics: Animals; Benzazepines; Cardiovascular Agents; Cricetinae; Disease Models, Animal; Ivabradine; Male; Mesocricetus; Microcirculation; Sepsis	2017
Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure. Journal of immunology research, 2016, Volume: 2016 Topics: Adrenergic beta-Antagonists; Adult; Aged; Benzazepines; Biomarkers; Cardiovascular Agents; Chronic Disease; Comorbidity; Cytokines; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Inflammation Mediators; Ivabradine; Male; Middle Aged; Quality of Life; Risk Factors; Treatment Outcome	2016
The Effects of Ivabradine on Cardiac Function after Myocardial Infarction are Weaker in Diabetic Rats. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 39, Issue:5 Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Vessels; Diabetes Mellitus, Experimental; Disease Models, Animal; Echocardiography; Heart Failure; Heart Function Tests; Hyperglycemia; Ivabradine; Ligation; Male; Myocardial Infarction; Nerve Tissue Proteins; Norepinephrine; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin	2016
Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs. Heart and vessels, 2017, Volume: 32, Issue:4 Topics: Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Dogs; Electric Stimulation; Electrophysiological Phenomena; Female; Heart Atria; Heart Rate; Ivabradine; Male; Vagus Nerve	2017
Antianginal Efficacy of Ivabradine/Metoprolol Combination in Patients With Stable Angina. Clinical cardiology, 2016, Volume: 39, Issue:12 Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Angina, Stable; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Ivabradine; Male; Metoprolol; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome	2016
Loeffler endocarditis in young woman - a case report. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2016, Nov-25, Volume: 41, Issue:245 Topics: Adult; Benzazepines; Bisoprolol; Cardiovascular Agents; Endocardium; Female; Humans; Hypereosinophilic Syndrome; Ivabradine; Poland; Retrospective Studies; Treatment Outcome	2016
Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Revista espanola de cardiologia (English ed.), 2016, Volume: 69, Issue:12 Topics: Acute Disease; Adrenergic beta-Antagonists; Algorithms; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biphenyl Compounds; Cardiac Resynchronization Therapy; Cardiovascular Agents; Chronic Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Combinations; Early Medical Intervention; Echocardiography; Europe; Extracorporeal Membrane Oxygenation; Heart Failure; Humans; Ivabradine; Mineralocorticoid Receptor Antagonists; Natriuretic Peptides; Practice Guidelines as Topic; Spain; Stroke Volume; Tetrazoles; Valsartan	2016
Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug? International journal of cardiology, 2017, Jun-01, Volume: 236 Topics: Action Potentials; Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Drug Delivery Systems; Ivabradine; Organ Culture Techniques; Rabbits; Treatment Outcome	2017
[Causes of Angina Pectoris in Survivors of Myocardial Infarction and the Role of Optimization of Antianginal Therapy. Data of the LINKOR Study E..] Kardiologiia, 2016, Volume: 56, Issue:11 Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Female; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Quality of Life; Risk Factors	2016
[Assessment of Efficiency of Medicamentous Therapy in Correction of Structurally Functional Changes of The Cardiac Muscle at Patients With Arterial Hypertension in Combination With Bronchial Asthma]. Kardiologiia, 2016, Volume: 56, Issue:6 Topics: Aged; Asthma; Benzazepines; Cardiovascular Agents; Electrocardiography; Electrocardiography, Ambulatory; Heart; Heart Rate; Humans; Hypertension; Ivabradine; Middle Aged	2016
[Regulatory Adaptive Status in Assessment of Efficacy of Pharmacotherapy and Prognostication of Complications in Functional Class III Chronic Heart Failure]. Kardiologiia, 2016, Volume: 56, Issue:1 Topics: Aged; Benzazepines; Cardiovascular Agents; Chronic Disease; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Hypertension; Ivabradine; Male; Metoprolol; Middle Aged; Quinapril; Random Allocation; Spironolactone; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Function, Left	2016
[Clinical Efficacy and Safety of Early Administration of Ivabradine in Patients With Acute Coronary Syndrome]. Kardiologiia, 2015, Volume: 55, Issue:12 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Benzazepines; Cardiovascular Agents; Female; Heart Rate; Humans; Ivabradine; Male; Treatment Outcome	2015
[Coronary Heart Disease at the Patient With Metabolic Syndrome: Strategy of Antianginal Therapy]. Kardiologiia, 2016, Volume: 56, Issue:4 Topics: Benzazepines; Cardiovascular Agents; Coronary Disease; Heart Rate; Humans; Ivabradine; Metabolic Syndrome	2016
Ivabradine in acute decompensated systolic heart failure. International journal of cardiology, 2017, 05-15, Volume: 235 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine	2017
Ivabradine in acute decompensated systolic heart failure. International journal of cardiology, 2017, 05-15, Volume: 235 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine	2017
Long-term treatment with ivabradine over 12months in patients with chronic heart failure in clinical practice: Effect on symptoms, quality of life and hospitalizations. International journal of cardiology, 2017, Aug-01, Volume: 240 Topics: Aged; Benzazepines; Cardiovascular Agents; Chronic Disease; Cohort Studies; Drug Administration Schedule; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Quality of Life; Time Factors; Treatment Outcome	2017
Respiration driven excessive sinus tachycardia treated with clonidine. BMJ case reports, 2017, Apr-28, Volume: 2017 Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Benzazepines; Cardiovascular Agents; Clonidine; Cough; Drug Therapy, Combination; Dyspnea; Echocardiography; Electrocardiography; Humans; Inhalation; Ivabradine; Male; Syncope; Tachycardia; Tachycardia, Sinus; Treatment Outcome	2017
Ivabradine attenuates the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice. Epilepsy research, 2017, Volume: 133 Topics: Acetamides; Animals; Anticonvulsants; Benzazepines; Brain; Cardiovascular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Epilepsy, Tonic-Clonic; Fructose; Ivabradine; Lacosamide; Lamotrigine; Male; Mice; Pregabalin; Topiramate; Triazines	2017
Effect of exercise on passive myocardial stiffness in mice with diastolic dysfunction. Journal of molecular and cellular cardiology, 2017, Volume: 108 Topics: Adaptation, Physiological; Animals; Benzazepines; Biomarkers; Cardiovascular Agents; Connectin; Diastole; Disease Models, Animal; Echocardiography; Gene Expression; Heart Failure; Heart Function Tests; Ivabradine; Male; Mice; Myocardial Contraction; Myocardium; Phosphorylation; Physical Conditioning, Animal	2017
Ivabradine as an Alternative to AV Node Ablation in a Patient With Permanent Atrial Fibrillation. Revista espanola de cardiologia (English ed.), 2017, Volume: 70, Issue:11 Topics: Atrial Fibrillation; Atrioventricular Node; Benzazepines; Cardiovascular Agents; Catheter Ablation; Electrocardiography; Humans; Ivabradine; Male; Middle Aged	2017
How does ivabradine effect erectile dysfunction in patients with heart failure? Kardiologia polska, 2017, Volume: 75, Issue:9 Topics: Benzazepines; Cardiovascular Agents; Erectile Dysfunction; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Surveys and Questionnaires; Treatment Outcome	2017
[A New Insight on Anti-Ischemic Action of Ivabradine in Patients With Stable Angina]. Kardiologiia, 2017, Volume: 57, Issue:3 Topics: Angina, Stable; Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Hemodynamics; Humans; Ivabradine; Myocardial Ischemia; Sinoatrial Node	2017
Evolving Pharmacologic Therapies for Heart Failure. South Dakota medicine : the journal of the South Dakota State Medical Association, 2017, Volume: 70, Issue:4 Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Benzazepines; Biphenyl Compounds; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Ivabradine; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Tetrazoles; Valsartan	2017
Effects of heart rate reduction with ivabradine on the international ındex of erectile function (IIEF-5) in patients with heart failure. The aging male : the official journal of the International Society for the Study of the Aging Male, 2018, Volume: 21, Issue:2 Topics: Aged; Analysis of Variance; Benzazepines; Cardiovascular Agents; Echocardiography; Erectile Dysfunction; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Penile Erection; Pilot Projects; Quality of Life; Surveys and Questionnaires; Turkey	2018
Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience. Pacing and clinical electrophysiology : PACE, 2017, Volume: 40, Issue:11 Topics: Adult; Benzazepines; Cardiovascular Agents; Female; Heart Rate; Humans; Ivabradine; Male; Postural Orthostatic Tachycardia Syndrome; Retrospective Studies; Treatment Outcome	2017
Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure. Circulation. Heart failure, 2017, Volume: 10, Issue:9 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Eligibility Determination; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Patient Selection; Registries; Stroke Volume; Sweden; Time Factors; Treatment Outcome; Ventricular Function, Left	2017
Differential Effects of HCN Channel Block on On and Off Pathways in the Retina as a Potential Cause for Medication-Induced Phosphene Perception. Investigative ophthalmology & visual science, 2017, 09-01, Volume: 58, Issue:11 Topics: Animals; Benzazepines; Cardiovascular Agents; Cells, Cultured; Disease Models, Animal; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Mice; Mice, Inbred C57BL; Phosphenes; Potassium Channel Blockers; Retina; Retinal Ganglion Cells	2017
Ivabradine in Postural Orthostatic Tachycardia Syndrome: Preliminary Experience in Children. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018, Volume: 18, Issue:1 Topics: Adolescent; Benzazepines; Cardiovascular Agents; Child; Electrocardiography; Female; Humans; Ivabradine; Male; Postural Orthostatic Tachycardia Syndrome; Retrospective Studies	2018
Cardiovascular drugs. Nursing, 2017, Volume: 47, Issue:11 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Pyridines; Thiazoles	2017
Ivabradine - well tolerated in elderly patients with systolic heart failure. International journal of cardiology, 2017, 12-15, Volume: 249 Topics: Aged; Benzazepines; Cardiovascular Agents; Heart Failure; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Treatment Outcome	2017
Ivabradine improves left ventricular twist and untwist during chronic hypertension. International journal of cardiology, 2018, Feb-01, Volume: 252 Topics: Animals; Benzazepines; Cardiovascular Agents; Chronic Disease; Female; Hypertension; Hypertrophy, Left Ventricular; Ivabradine; Swine; Ventricular Dysfunction, Left	2018
Drug action(s), drug marketing, and clinical medicine. Suppression of ventricular arrhythmogenicity with If blockade in human heart failure: emerging clinical evidence for ivabradine treatment benefit beyond heart rate control. Kardiologia polska, 2017, Volume: 75, Issue:12 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Marketing	2017
Effect of Early Treatment With Ivabradine Plus Beta-blockers on Long-term Outcomes in Patients Hospitalized With Systolic Heart Failure. Revista espanola de cardiologia (English ed.), 2018, Volume: 71, Issue:12 Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Stroke Volume; Time Factors; Treatment Outcome	2018
[Ivabradine in Modern Pharmacotherapy of Cardiovascular Diseases - Realities and Prospects]. Kardiologiia, 2018, Issue:2 Topics: Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Heart Rate; Humans; Ivabradine	2018
Ivabradine for systolic heart failure. JAAPA : official journal of the American Academy of Physician Assistants, 2018, Volume: 31, Issue:3 Topics: Benzazepines; Cardiovascular Agents; Diastole; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Systole; Treatment Outcome	2018
Ivabradine does not acutely affect open-loop baroreflex static characteristics and spares sympathetic heart rate control in rats. International journal of cardiology, 2018, 04-15, Volume: 257 Topics: Animals; Baroreflex; Benzazepines; Blood Pressure; Cardiovascular Agents; Dose-Response Relationship, Drug; Heart Rate; Ivabradine; Pressoreceptors; Rats; Rats, Inbred WKY; Sympathetic Nervous System	2018
Heart rate-reducing therapy with add-on ivabradine and bisoprolol before coronary computed tomographic angiography in a fast-track ambulatory setting. The Journal of international medical research, 2018, Volume: 46, Issue:6 Topics: Aged; Bisoprolol; Cardiovascular Agents; Clinical Protocols; Computed Tomography Angiography; Coronary Artery Disease; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Retrospective Studies	2018
Optimization of heart rate lowering therapy in hospitalized patients with heart failure: Insights from the Optimize Heart Failure Care Program. International journal of cardiology, 2018, 06-01, Volume: 260 Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Cardiovascular Agents; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Retrospective Studies	2018
DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE. Acta poloniae pharmaceutica, 2017, Volume: 74, Issue:2 Topics: Acrylic Resins; Benzazepines; Calorimetry, Differential Scanning; Cardiovascular Agents; Cellulose; Chemistry, Pharmaceutical; Crystallography, X-Ray; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Hydrogen-Ion Concentration; Ivabradine; Kinetics; Microscopy, Electron, Scanning; Microspheres; Models, Chemical; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical; Thermogravimetry	2017
Possible Ameliorative Effect of Ivabradine on the Autonomic and Left Ventricular Dysfunction Induced by Doxorubicin in Male Rats. Journal of cardiovascular pharmacology, 2018, Volume: 72, Issue:1 Topics: Animals; Arterial Pressure; Autonomic Nervous System; Autonomic Nervous System Diseases; Baroreflex; Cardiotoxicity; Cardiovascular Agents; Cardiovascular System; Disease Models, Animal; Doxorubicin; Heart Failure; Heart Rate; Ivabradine; Male; Rats, Wistar; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure	2018
Mechano-chronotropic Unloading During the Acute Phase of Myocardial Infarction Markedly Reduces Infarct Size via the Suppression of Myocardial Oxygen Consumption. Journal of cardiovascular translational research, 2019, Volume: 12, Issue:2 Topics: Animals; Cardiovascular Agents; Combined Modality Therapy; Disease Models, Animal; Dogs; Heart Rate; Heart-Assist Devices; Ivabradine; Myocardial Infarction; Myocardium; Oxygen Consumption; Prosthesis Design; Prosthesis Implantation; Recovery of Function; Ventricular Function, Left	2019
Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure. Journal of cardiovascular medicine (Hagerstown, Md.), 2018, Volume: 19, Issue:7 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiovascular Agents; Chronic Disease; Echocardiography; Female; Heart Failure, Systolic; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Retrospective Studies; Stroke Volume; Ventricular Function, Left	2018
The Effectiveness of Trimetazidine Treatment in Patients with Stable Angina Pectoris of Various Durations: Results from the CHOICE-2 Study. Advances in therapy, 2018, Volume: 35, Issue:7 Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiovascular Agents; Drug Therapy, Combination; Exercise; Exercise Test; Exercise Tolerance; Female; Humans; Ivabradine; Male; Middle Aged; Nitrates; Prospective Studies; Quality of Life; Research Design; Russia; Time Factors; Trimetazidine; Vasodilator Agents; Walk Test	2018
Ivabradine improved left ventricular function and pressure overload-induced cardiomyocyte apoptosis in a transverse aortic constriction mouse model. Molecular and cellular biochemistry, 2019, Volume: 450, Issue:1-2 Topics: Animals; Aortic Diseases; Apoptosis; Cardiovascular Agents; Constriction, Pathologic; Disease Models, Animal; Hypertrophy, Left Ventricular; Ivabradine; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Pressure; Ventricular Dysfunction, Left	2019
Ivabradine is an effective antiarrhythmic therapy for congenital junctional ectopic tachycardia-induced cardiomyopathy during infancy: Case studies. Pacing and clinical electrophysiology : PACE, 2018, Volume: 41, Issue:10 Topics: Cardiomyopathies; Cardiovascular Agents; Electrocardiography; Female; Humans; Infant; Ivabradine; Male; Tachycardia, Ectopic Junctional	2018
Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Pacing and clinical electrophysiology : PACE, 2018, Volume: 41, Issue:10 Topics: Adolescent; Anti-Arrhythmia Agents; Cardiovascular Agents; Electrocardiography; Exercise Test; Female; Flecainide; Humans; Ivabradine; Male; Nadolol; Tachycardia, Ventricular; Young Adult	2018
Ivabradine in acute heart failure: Effects on heart rate and hemodynamic parameters in a randomized and controlled swine trial. Cardiology journal, 2020, Volume: 27, Issue:1 Topics: Acute Disease; Animals; Arterial Pressure; Cardiac Output; Cardiovascular Agents; Disease Models, Animal; Female; Heart Failure; Heart Rate; Ivabradine; Myocardial Infarction; Sus scrofa; Time Factors	2020
Facts and details: Ivabradine in acute decompensated heart failure. International journal of cardiology, 2018, 11-01, Volume: 270 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine	2018
Facts and details: Ivabradine in acute decompensated heart failure. International journal of cardiology, 2018, 11-15, Volume: 271 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine	2018
The effect of the heart rate lowering drug Ivabradine on hemodynamics in atherosclerotic mice. Scientific reports, 2018, 09-18, Volume: 8, Issue:1 Topics: Animals; Atherosclerosis; Cardiovascular Agents; Disease Models, Animal; Heart Rate; Hemodynamics; Ivabradine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Stress, Mechanical	2018
Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community. International journal of clinical practice, 2018, Volume: 72, Issue:11 Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Cardiovascular Agents; Cohort Studies; Comorbidity; Digoxin; Female; Heart Failure; Hospitalization; Humans; Ivabradine; Male; Patient Readmission; Prognosis; Stroke Volume; Treatment Outcome	2018
Heart Failure Differentially Modulates the Effects of Ivabradine on the Electrical Activity of the Sinoatrial Node and Pulmonary Veins. Journal of cardiac failure, 2018, Volume: 24, Issue:11 Topics: Action Potentials; Animals; Cardiovascular Agents; Disease Models, Animal; Echocardiography; Electrocardiography, Ambulatory; Heart Failure; Heart Rate; Ivabradine; Male; Pulmonary Veins; Rabbits; Sinoatrial Node; Stroke Volume	2018
Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure. Physiological reports, 2018, Volume: 6, Issue:19 Topics: Animals; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dobutamine; Drug Therapy, Combination; Heart Failure; Ivabradine; Male; Myocardial Ischemia; Swine; Treatment Outcome; Urea	2018
Postural Orthostatic Tachycardia Syndrome and Vasospastic Angina: Therapeutic Approach to a Previously Unreported Association. Revista espanola de cardiologia (English ed.), 2019, Volume: 72, Issue:6 Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Anti-Inflammatory Agents; Cardiovascular Agents; Coronary Angiography; Drug Therapy, Combination; Electrocardiography; Female; Fludrocortisone; Humans; Ivabradine; Middle Aged; Postural Orthostatic Tachycardia Syndrome; Propranolol; Tilt-Table Test	2019
Ivabradine promotes angiogenesis and reduces cardiac hypertrophy in mice with myocardial infarction. Anatolian journal of cardiology, 2018, Volume: 20, Issue:5 Topics: Administration, Oral; Angiogenesis Inducing Agents; Animals; Cardiomegaly; Cardiovascular Agents; Disease Models, Animal; Echocardiography; Electrocardiography; Heart Rate; Ivabradine; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type III; Random Allocation	2018
Potential use of ivabradine for treatment of atrial fibrillation. Journal of cardiovascular electrophysiology, 2019, Volume: 30, Issue:2 Topics: Animals; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Ivabradine; Mice; Mice, Transgenic	2019
Ivabradine abrogates TNF-α-induced degradation of articular cartilage matrix. International immunopharmacology, 2019, Volume: 66 Topics: ADAMTS4 Protein; Anti-Inflammatory Agents; Cardiovascular Agents; Cartilage, Articular; Cells, Cultured; Chondrocytes; Collagen Type II; Extracellular Matrix; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Interleukin-1beta; Interleukin-6; Ivabradine; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; NF-kappa B; Osteoarthritis; Potassium Channels; RNA, Small Interfering; Signal Transduction; Tumor Necrosis Factor-alpha	2019
Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry. JACC. Heart failure, 2019, Volume: 7, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Cross-Sectional Studies; Female; Furosemide; Guideline Adherence; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Netherlands; Practice Guidelines as Topic; Registries; Renin-Angiotensin System; Sodium Potassium Chloride Symporter Inhibitors; Spironolactone; Stroke Volume	2019
Heart rate reduction strategy using ivabradine in end-stage Duchenne cardiomyopathy. International journal of cardiology, 2019, 04-01, Volume: 280 Topics: Adolescent; Adult; Cardiomyopathies; Cardiovascular Agents; Cohort Studies; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Magnetic Resonance Imaging, Cine; Male; Muscular Dystrophy, Duchenne; Pilot Projects; Prospective Studies; Young Adult	2019
Ivabradine for heart failure: regulatory differences in Europe and United States. European heart journal. Cardiovascular pharmacotherapy, 2019, 04-01, Volume: 5, Issue:2 Topics: Cardiovascular Agents; Drug Approval; Europe; Evidence-Based Medicine; Government Regulation; Healthcare Disparities; Heart Failure; Humans; Ivabradine; Patient Safety; Policy Making; Risk Assessment; Risk Factors; United States; United States Food and Drug Administration	2019
Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure. Journal of cardiovascular pharmacology and therapeutics, 2019, Volume: 24, Issue:4 Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Bisoprolol; Cardiovascular Agents; Disease Models, Animal; Heart; Heart Failure; Heart Rate; Hypertension; Ivabradine; Male; Myocardium; Norepinephrine; Parasympathetic Nervous System; Rats, Inbred Dahl; Sodium Chloride, Dietary; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Ventricular Function, Left	2019
Ivabradine reduces baseline and stress-induced increase of heart rate and blood pressure and modulates neuroendocrine stress response in rats depending on stressor intensity. General physiology and biophysics, 2019, Volume: 38, Issue:2 Topics: Animals; Blood Pressure; Cardiovascular Agents; Corticosterone; Epinephrine; Heart Rate; Ivabradine; Norepinephrine; Rats; Restraint, Physical	2019
Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction. Chemotherapy, 2018, Volume: 63, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Cardiovascular Agents; Dose-Response Relationship, Drug; Fatigue; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Neoplasms; Retrospective Studies; Trastuzumab; Ventricular Dysfunction, Left	2018
Ivabradine in Catecholamine-Induced Tachycardia in a Patient with Paraganglioma. The New England journal of medicine, 2019, 03-28, Volume: 380, Issue:13 Topics: Cardiovascular Agents; Catecholamines; Humans; Ivabradine; Male; Middle Aged; Norepinephrine; Octreotide; Organometallic Compounds; Paraganglioma; Tachycardia	2019
Efficacy of ivabradine for heart failure: A protocol for a systematic review of randomized controlled trial. Medicine, 2019, Volume: 98, Issue:14 Topics: Cardiovascular Agents; China; Heart Failure; Humans; Ivabradine; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic	2019
Is ivabradine a wonder drug for atypical POTS? BMJ case reports, 2019, Apr-20, Volume: 12, Issue:4 Topics: Cardiovascular Agents; Electrocardiography; Female; Humans; Ivabradine; Postural Orthostatic Tachycardia Syndrome; Syncope; Tilt-Table Test; Young Adult	2019
Crystal structures and properties of two hydrated conglomerate forms of the heart-rate-lowering agent ivabradine hydrochloride. Acta crystallographica. Section C, Structural chemistry, 2019, May-01, Volume: 75, Issue:Pt 5 Topics: Calorimetry, Differential Scanning; Cardiovascular Agents; Drug Stability; Hydrogen Bonding; Ivabradine; Models, Molecular; Molecular Conformation; Thermodynamics; Water; X-Ray Diffraction	2019
Locally injected ivabradine inhibits carrageenan-induced pain and inflammatory responses via hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. PloS one, 2019, Volume: 14, Issue:5 Topics: Animals; Cardiovascular Agents; Carrageenan; Gene Expression Regulation; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Inflammation; Ivabradine; Male; Pain; Potassium Channels; Rats; Rats, Sprague-Dawley	2019
Pharmacological Profile of the Bradycardic Agent Ivabradine on Human Cardiac Ion Channels. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2019, Volume: 53, Issue:1 Topics: Action Potentials; Calcium Channels, L-Type; Cardiovascular Agents; Cell Line; ERG1 Potassium Channel; Humans; Induced Pluripotent Stem Cells; Ion Channels; Ivabradine; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques	2019
Beneficial Effects of Ivabradine on Post-Resuscitation Myocardial Dysfunction in a Porcine Model of Cardiac Arrest. Shock (Augusta, Ga.), 2020, Volume: 53, Issue:5 Topics: Animals; Cardiomyopathies; Cardiopulmonary Resuscitation; Cardiovascular Agents; Disease Models, Animal; Heart Arrest; Ivabradine; Male; Stroke Volume; Swine; Ventricular Function, Left	2020
Ivabradine in Post-operative Junctional Ectopic Tachycardia (JET): Breaking New Ground. Pediatric cardiology, 2019, Volume: 40, Issue:6 Topics: Administration, Intranasal; Cardiac Surgical Procedures; Cardiovascular Agents; Child, Preschool; Female; Humans; Infant; Ivabradine; Male; Postoperative Complications; Retrospective Studies; Tachycardia, Ectopic Junctional; Treatment Outcome	2019
[Proportion of patients with heart failure in a specialized clinic eligible for novel therapies]. Revista medica de Chile, 2019, Volume: 147, Issue:3 Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiovascular Agents; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Combinations; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Patient Selection; Tetrazoles; Valsartan	2019
Clinical and Electrophysiological Correlates of Incessant Ivabradine-Sensitive Atrial Tachycardia. Circulation. Arrhythmia and electrophysiology, 2019, Volume: 12, Issue:8 Topics: Administration, Oral; Adult; Atrial Function, Left; Cardiovascular Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Heart Atria; Heart Rate; Humans; Ivabradine; Male; Prospective Studies; Tachycardia, Supraventricular; Treatment Outcome	2019
Ivabradine modulates the autonomic nervous system by affecting the "little brain" of the heart: A hypothesis. Medical hypotheses, 2019, Volume: 129 Topics: Animals; Autonomic Nervous System; Autonomic Nervous System Diseases; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Models, Theoretical; Rats; Sinoatrial Node	2019
Ivabradine drug utilization study in five European countries: A multinational, retrospective, observational study to assess effectiveness of risk-minimization measures. Pharmacoepidemiology and drug safety, 2019, Volume: 28, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angina, Stable; Cardiovascular Agents; Cohort Studies; Drug Utilization; Europe; Female; Guideline Adherence; Humans; Ivabradine; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Risk Management; Young Adult	2019
Baseline intrinsic heart rate and response to ivabradine treatment in patients with inappropriate sinus tachycardia. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2020, Volume: 25, Issue:3 Topics: Adult; Cardiovascular Agents; Electrocardiography; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Tachycardia, Sinus; Treatment Outcome; Young Adult	2020
Pharmacological treatment patterns in heart failure: a population-based cohort study. European journal of clinical pharmacology, 2020, Volume: 76, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Clinical Protocols; Cohort Studies; Digoxin; Diuretics; Drug Substitution; Female; France; Heart Failure; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Time Factors	2020
Ivabradine as an Adjunct for Refractory Junctional Ectopic Tachycardia Following Pediatric Cardiac Surgery: A Preliminary Study. World journal for pediatric & congenital heart surgery, 2019, Volume: 10, Issue:6 Topics: Cardiac Surgical Procedures; Cardiovascular Agents; Electrocardiography; Female; Heart Defects, Congenital; Heart Rate; Humans; Infant; Ivabradine; Male; Postoperative Complications; Retrospective Studies; Tachycardia, Ectopic Junctional; Treatment Outcome	2019
Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure. JAMA cardiology, 2020, 03-01, Volume: 5, Issue:3 Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiovascular Agents; Drug Combinations; Drug Utilization; Heart Failure; Humans; Ivabradine; Medicaid; Medicare Part D; Tetrazoles; United States; Valsartan	2020
Heart Rate Control during Experimental Sepsis in Mice: Comparison of Ivabradine and β-Blockers. Anesthesiology, 2020, Volume: 132, Issue:2 Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; Heart Rate; Ivabradine; Male; Mice; Mice, Inbred C57BL; Random Allocation; Sepsis	2020
The use of ivabradine in a patient with inappropriate sinus tachycardia and cardiomyopathy due to limb girdle muscular dystrophy type 2I. BMJ case reports, 2020, Jan-21, Volume: 13, Issue:1 Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Cardiovascular Agents; Diagnosis, Differential; Female; Humans; Ivabradine; Metoprolol; Muscular Dystrophies, Limb-Girdle; Tachycardia, Sinus; Young Adult	2020
Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy. Pacing and clinical electrophysiology : PACE, 2020, Volume: 43, Issue:5 Topics: Adolescent; Cardiovascular Agents; Electrocardiography; Exercise Test; Flecainide; Humans; Ivabradine; Male; Nadolol; Phenotype; Sympathectomy; Tachycardia, Ventricular	2020
Fatal intoxication with ivabradine: First case report. Forensic science international, 2020, Volume: 311 Topics: Brain Chemistry; Cardiovascular Agents; Chromatography, Liquid; Drug Overdose; Female; Forensic Toxicology; Humans; Ivabradine; Kidney; Liver; Lung; Middle Aged; Myocardium; Tandem Mass Spectrometry; Vitreous Body	2020
A case of highly disabling orthostatic hypotension: when an integrated cardiac rehabilitation approach makes the difference. Giornale italiano di medicina del lavoro ed ergonomia, 2020, Volume: 42, Issue:2 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiac Rehabilitation; Cardiovascular Agents; Humans; Hypotension, Orthostatic; Ivabradine; Male; Myocardial Ischemia; Quality of Life; Standing Position; Tilt-Table Test; Time Factors	2020
Translating GWAS-identified loci for cardiac rhythm and rate using an in vivo image- and CRISPR/Cas9-based approach. Scientific reports, 2020, 07-16, Volume: 10, Issue:1 Topics: Animals; Animals, Genetically Modified; Bradycardia; Cardiovascular Agents; CRISPR-Cas Systems; Embryo, Nonmammalian; Genes, Reporter; Genome-Wide Association Study; Green Fluorescent Proteins; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Meta-Analysis as Topic; Myocardial Contraction; Myocytes, Smooth Muscle; Optical Imaging; Pleckstrin Homology Domains; RGS Proteins; Zebrafish	2020
Ivabradine-Induced Torsade de Pointes in Patients with Heart Failure Reduced Ejection Fraction. International heart journal, 2020, Sep-29, Volume: 61, Issue:5 Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Drug Interactions; Electric Countershock; Electrocardiography; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Torsades de Pointes	2020
Effect of early use of ivabradine on left ventricular remodeling after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: A pilot test. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2021, Volume: 26, Issue:2 Topics: Acute Disease; Cardiovascular Agents; Female; Humans; Ivabradine; Male; Middle Aged; Percutaneous Coronary Intervention; Pilot Projects; ST Elevation Myocardial Infarction; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling	2021
Ivabradine effects on heart rate and quality of life among chronic heart failure patients. JPMA. The Journal of the Pakistan Medical Association, 2021, Volume: 71, Issue:1(A) Topics: Adult; Aged; Benzazepines; Cardiovascular Agents; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Quality of Life; Treatment Outcome	2021
Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox database. European journal of clinical pharmacology, 2021, Volume: 77, Issue:7 Topics: Abortion, Spontaneous; Adult; Cardiovascular Agents; Congenital Abnormalities; Female; Humans; Ivabradine; Pregnancy; Pregnancy Outcome; Retrospective Studies; Tachycardia, Supraventricular	2021
Comment on: Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: Rationale and design of SHIFT-AHF trial. ESC heart failure, 2021, Volume: 8, Issue:2 Topics: Cardiovascular Agents; Heart Failure; Humans; Ivabradine	2021
An Integrative Approach for Improved Assessment of Cardiovascular Safety Data. The Journal of pharmacology and experimental therapeutics, 2021, Volume: 377, Issue:2 Topics: Animals; Biomarkers, Pharmacological; Blood Pressure; Cardiotoxicity; Cardiovascular Agents; Heart Rate; Ivabradine; Male; Phenethylamines; Pyridazines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfonamides	2021
Inhibitory effect of sesamin on ivabradine metabolism in rats. Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:6 Topics: Administration, Oral; Animals; Area Under Curve; Cardiovascular Agents; Chromatography, High Pressure Liquid; Dioxoles; Ivabradine; Lignans; Male; Rats, Sprague-Dawley; Tandem Mass Spectrometry	2020
Nano-ivabradine averts behavioral anomalies in Huntington's disease rat model via modulating Rhes/m-tor pathway. Progress in neuro-psychopharmacology & biological psychiatry, 2021, 12-20, Volume: 111 Topics: Animals; Autophagy; Cardiovascular Agents; Corpus Striatum; Disease Models, Animal; Huntington Disease; Ivabradine; Male; Nanoparticle Drug Delivery System; Neuroprotective Agents; Nitro Compounds; Propionates; Rats; TOR Serine-Threonine Kinases	2021
Chronotropic Assessment in Patients with Constrictive Pericarditis. International heart journal, 2021, Jul-30, Volume: 62, Issue:4 Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Pericarditis, Constrictive; Recurrence; Retrospective Studies	2021
Torsadogenic Potential of HCN Channel Blocker Ivabradine Assessed in the Rabbit Proarrhythmia Model. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:11 Topics: Animals; Atrioventricular Block; Cardiovascular Agents; Disease Models, Animal; Electrocardiography; Heart Rate; Hemodynamics; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Rabbits; Torsades de Pointes	2021
Real-World Effectiveness of Ivabradine in Chinese Patients with Chronic Heart Failure: Interim Analysis of the POSITIVE Study. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022, Volume: 22, Issue:3 Topics: Adult; Benzazepines; Cardiovascular Agents; China; Chronic Disease; Heart Failure; Heart Rate; Humans; Ivabradine; Prospective Studies; Quality of Life; Treatment Outcome; Ventricular Function, Left	2022
Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy. International heart journal, 2022, Volume: 63, Issue:1 Topics: Aged; Cardiovascular Agents; Coronary Circulation; Echocardiography; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Mitral Valve; Prognosis; Proportional Hazards Models; Retrospective Studies; Stroke Volume	2022
Efficacy of Doppler echocardiography-guided ivabradine therapy. Heart and vessels, 2023, Volume: 38, Issue:1 Topics: Benzazepines; Cardiovascular Agents; Echocardiography, Doppler; Heart Failure; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Stroke Volume; Ventricular Function, Left	2023
Initiating ivabradine during hospitalization in patients with acute heart failure: A real-world experience in China. Clinical cardiology, 2022, Volume: 45, Issue:9 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left	2022
The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy: Quo Vadis? Journal of the American College of Cardiology, 2022, 08-09, Volume: 80, Issue:6 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Treatment Outcome	2022
Ivabradine in the Management of Pediatric Arrhythmias. The Canadian journal of cardiology, 2023, Volume: 39, Issue:1 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Agents; Child; Heart Rate; Humans; Ivabradine	2023
Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction. European journal of heart failure, 2023, Volume: 25, Issue:8 Topics: Benzazepines; Bradycardia; Cardiovascular Agents; Heart Failure; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Stroke Volume; Treatment Outcome	2023
Optimizing heart rate with ivabradine in heart failure with reduced ejection fraction: Insights from a post-hoc analysis of the SHIFT trial. European journal of heart failure, 2023, Volume: 25, Issue:8 Topics: Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Stroke Volume; Treatment Outcome	2023
Serum Ivabradine Associates With Heart Rate Reduction But Enteral Exposure Is Unpredictable in Post surgical JET. JACC. Clinical electrophysiology, 2023, Volume: 9, Issue:8 Pt 3 Topics: Bradycardia; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Tachycardia, Ectopic Junctional	2023